This is a Validated Antibody Database (VAD) review about mouse L selectin, based on 448 published articles (read how Labome selects the articles), using L selectin antibody in all methods. It is aimed to help Labome visitors find the most suited L selectin antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
L selectin synonym: AI528707; CD62L; L-selectin; LECAM-1; Lnhr; Ly-22; Ly-m22; Lyam-1; Lyam1

others
 L selectin antibody (Biolegend, MEL-14) was used . BMC Biol (2020) ncbi
  • flow cytometry; mouse; loading ...; fig s1a
 L selectin antibody (Biolegend, MEL-14) was used in flow cytometry on mouse samples (fig s1a). Aging (Albany NY) (2020) ncbi
 L selectin antibody (Bio-Legend, MEL-14) was used . BMC Infect Dis (2019) ncbi
 L selectin antibody (BioLegend, Mel-14) was used . Aging (Albany NY) (2019) ncbi
  • flow cytometry; mouse; loading ...; fig 1a
 L selectin antibody (BioLegend, MEL-14) was used in flow cytometry on mouse samples (fig 1a). J Clin Invest (2019) ncbi
  • flow cytometry; mouse; loading ...; fig s3e
 L selectin antibody (Biolegend, MEL-14) was used in flow cytometry on mouse samples (fig s3e). JCI Insight (2019) ncbi
 L selectin antibody (BioLegend, MEL-14) was used . J Immunol (2019) ncbi
 L selectin antibody (BioLegend, MEL-14) was used . Nature (2019) ncbi
 L selectin antibody (Biolegend, MEL-14) was used . Cell Rep (2019) ncbi
 L selectin antibody (BioLegend, MEL-14) was used . J Exp Med (2018) ncbi
 L selectin antibody (BioLegend, MEL-14) was used . J Clin Invest (2018) ncbi
 L selectin antibody (BioLegend, Mel-14) was used . J Clin Invest (2018) ncbi
 L selectin antibody (BioLegend, MEL-14) was used . J Exp Med (2018) ncbi
 L selectin antibody (BioLegend, MEL-14) was used . J Virol (2018) ncbi
 L selectin antibody (BioLegend, MEL-14) was used . Nat Immunol (2018) ncbi
 L selectin antibody (Biolegend, MEL-14) was used . Nat Immunol (2018) ncbi
 L selectin antibody (BioLegend, MEL-14) was used . J Immunol (2018) ncbi
 L selectin antibody (Biolegend, MEL-14) was used . Nat Commun (2017) ncbi
 L selectin antibody (BioLegend, MEL-14) was used . J Exp Med (2017) ncbi
In order to characterize mitochondrial changes in T cells due to PD-1 blockade therapy, L selectin antibody (BioLegend, MEL-14) was used . Proc Natl Acad Sci U S A (2017) ncbi
Invitrogen
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig s3a, s3c
Invitrogen L selectin antibody (eBioscience, 17-0621-83) was used in flow cytometry on mouse samples (fig s3a, s3c). PLoS Pathog (2022) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 1b, s3
Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples (fig 1b, s3). Int J Mol Sci (2022) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; 1:200; loading ...; fig 6j
Invitrogen L selectin antibody (Thermo Fisher, MEL-14) was used in flow cytometry on mouse samples at 1:200 (fig 6j). Sci Rep (2021) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; 1:200; loading ...; fig 2n
Invitrogen L selectin antibody (eBioscience, 56-0621-82) was used in flow cytometry on mouse samples at 1:200 (fig 2n). Front Immunol (2021) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 4b
Invitrogen L selectin antibody (eBioscience, (MEL-14) was used in flow cytometry on mouse samples (fig 4b). J Immunother Cancer (2021) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 1g
Invitrogen L selectin antibody (eBioscience, 11-0621-82) was used in flow cytometry on mouse samples (fig 1g). Adv Sci (Weinh) (2021) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; 1:800; loading ...; fig s5
Invitrogen L selectin antibody (eBiosciences, Mel-14) was used in flow cytometry on mouse samples at 1:800 (fig s5). Nat Commun (2021) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 10b
Invitrogen L selectin antibody (eBioscience, 47-0621-82) was used in flow cytometry on mouse samples (fig 10b). Mucosal Immunol (2021) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; 1:200; loading ...
Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples at 1:200. Nat Commun (2021) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 4f
Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples (fig 4f). Acta Naturae (2021) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; 1:100; fig 1a
Invitrogen L selectin antibody (Thermo Fisher Scientific, 17-0621-83) was used in flow cytometry on mouse samples at 1:100 (fig 1a). elife (2021) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 1a
Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples (fig 1a). elife (2021) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 4l
Invitrogen L selectin antibody (eBioscience, Mel14) was used in flow cytometry on mouse samples (fig 4l). Aging Cell (2021) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 1a
Invitrogen L selectin antibody (eBioscience, 17-0621-83) was used in flow cytometry on mouse samples (fig 1a). J Clin Invest (2020) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig s2d
Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples (fig s2d). Mucosal Immunol (2021) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig s5c
Invitrogen L selectin antibody (eBioscience/Thermo Fisher Scientific, MEL-14) was used in flow cytometry on mouse samples (fig s5c). Sci Adv (2020) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; human; 1:100; loading ...; fig 6a
Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on human samples at 1:100 (fig 6a). Front Immunol (2020) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 3c
Invitrogen L selectin antibody (eBioscience, 25-0621-81) was used in flow cytometry on mouse samples (fig 3c). elife (2020) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; 1:200; loading ...; fig 1s2a
Invitrogen L selectin antibody (eBioscience, 17-0621-83) was used in flow cytometry on mouse samples at 1:200 (fig 1s2a). elife (2020) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 1a, s1c
Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples (fig 1a, s1c). Sci Adv (2019) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig e10
Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples (fig e10). Nature (2019) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 2b
Invitrogen L selectin antibody (eBioscience, 11-0621-85) was used in flow cytometry on mouse samples (fig 2b). Cell (2019) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig s4b
Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples (fig s4b). J Clin Invest (2019) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 1e
Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples (fig 1e). J Clin Invest (2019) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; 1:200; loading ...; fig 3k
Invitrogen L selectin antibody (eBioscience, 12-0621-82) was used in flow cytometry on mouse samples at 1:200 (fig 3k). Nat Commun (2019) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; 1:100; loading ...
Invitrogen L selectin antibody (Thermo Fisher, MEL-14) was used in flow cytometry on mouse samples at 1:100. Nature (2019) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 1f
Invitrogen L selectin antibody (eBiosciences, MEL-14) was used in flow cytometry on mouse samples (fig 1f). J Exp Med (2019) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 6d
Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples (fig 6d). J Exp Med (2019) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 1a
Invitrogen L selectin antibody (eBiosciences, MEL-14) was used in flow cytometry on mouse samples (fig 1a). Nat Commun (2018) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 1b
Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples (fig 1b). Proc Natl Acad Sci U S A (2018) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; 1:300; loading ...; fig 3s2a
Invitrogen L selectin antibody (eBioscience, 17-0621-82) was used in flow cytometry on mouse samples at 1:300 (fig 3s2a). elife (2018) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig s7d
Invitrogen L selectin antibody (eBioscience, 47-0621-82) was used in flow cytometry on mouse samples (fig s7d). Nat Commun (2018) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig s1a
Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples (fig s1a). Blood (2018) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 2b
Invitrogen L selectin antibody (Thermo Fisher Scientific, MEL-14) was used in flow cytometry on mouse samples (fig 2b). Eur J Immunol (2018) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; 1:100; loading ...; fig 2a
Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples at 1:100 (fig 2a). Infect Immun (2018) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig e3c
Invitrogen L selectin antibody (eBiosciences, MEL-14) was used in flow cytometry on mouse samples (fig e3c). Nature (2018) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig s1d
Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples (fig s1d). J Clin Invest (2018) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 6a
Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples (fig 6a). Cancer Res (2018) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 1h
Invitrogen L selectin antibody (ebioscience, MEL-14) was used in flow cytometry on mouse samples (fig 1h). Nat Commun (2018) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 3a
Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples (fig 3a). Front Immunol (2018) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 1e
Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples (fig 1e). J Exp Med (2018) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 2a
Invitrogen L selectin antibody (eBioscience, MEL14) was used in flow cytometry on mouse samples (fig 2a). J Immunol (2018) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 4b
Invitrogen L selectin antibody (eBiosciences, MEL-14) was used in flow cytometry on mouse samples (fig 4b). J Cell Biol (2017) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig s6b
In order to investigate the effect of polymicrobial sepsis in skin immune response, Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples (fig s6b). PLoS Pathog (2017) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 3b
In order to study the involvement of the Ox40/Ox40 ligand pathway in systemic lupus erythematosus, Invitrogen L selectin antibody (eBioscience, 56-0621) was used in flow cytometry on mouse samples (fig 3b). J Immunol (2017) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 4c
In order to characterize the regulatory T cells expressing T-bet transcriptional factor, Invitrogen L selectin antibody (eBioscience, 25-0621-82) was used in flow cytometry on mouse samples (fig 4c). Nature (2017) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 3b
In order to characterize murine monocytes through transcriptome and genome analyses, Invitrogen L selectin antibody (eBioscience, 12-0621-81) was used in flow cytometry on mouse samples (fig 3b). Immunity (2017) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 1a
In order to investigate the role of Egr2 and 3 in adaptive immune responses and its mechanism, Invitrogen L selectin antibody (eBiosciences, 12-0621-81) was used in flow cytometry on mouse samples (fig 1a). J Exp Med (2017) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 4d
Invitrogen L selectin antibody (eBiosciences, MEL-14) was used in flow cytometry on mouse samples (fig 4d). J Immunol (2017) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig s1b
In order to study the effects of IL-10R signaling during Plasmodium berghei ANKA-induced experimental cerebral malaria, Invitrogen L selectin antibody (eBiosciences, MEL-14) was used in flow cytometry on mouse samples (fig s1b). Infect Immun (2017) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...
In order to assess the contribution of viral infection to the development of celiac disease, Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples . Science (2017) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig s2f
In order to study the role of moesin during the generation of TGF-beta-induced T regulatory cells, Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples (fig s2f). J Clin Invest (2017) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig s3d
In order to investigate the use of red blood cells expressing disease-associated autoantigenas a means of inducing antigen-specific tolerance, Invitrogen L selectin antibody (eBioscience, 17-0621-83) was used in flow cytometry on mouse samples (fig s3d). Proc Natl Acad Sci U S A (2017) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 1d
Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples (fig 1d). J Immunol (2017) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 4h
Invitrogen L selectin antibody (eBioscience, MEL14) was used in flow cytometry on mouse samples (fig 4h). Blood (2017) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 2c
In order to evaluate miR-29a in B cells as a potential therapeutic target in arthritis, Invitrogen L selectin antibody (eBiosciences, MEL-14) was used in flow cytometry on mouse samples (fig 2c). Cell Mol Life Sci (2017) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 6a
In order to explore if the anti-diabetic sulphonylurea glibenclamide protects insulin-producing cells against conditions mimicking those expected at the onset of type 1 diabetes, Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples (fig 6a). PLoS ONE (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig s1
In order to discuss differences in eosinophil degranulation between humans and mice, Invitrogen L selectin antibody (eBiosciences, MEL-14) was used in flow cytometry on mouse samples (fig s1). Am J Respir Crit Care Med (2017) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 1b
In order to find a role for RAB43 in cross-presentation by classical dendritic cells, Invitrogen L selectin antibody (eBiosciences, MEL-14) was used in flow cytometry on mouse samples (fig 1b). J Exp Med (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...
In order to suggest that persistent immune activation causes impairment of lymphocytes to respond to chemotactic stimuli, preventing their trafficking from the blood stream to peripheral organs, Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples . J Immunol (2017) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 2d
Invitrogen L selectin antibody (eBiosciences, MEL-14) was used in flow cytometry on mouse samples (fig 2d). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 10a
In order to study CD153+ PD-1+ CD44hi CD4+ T cells in the visceral adipose tissue of high fat diet-fed obese mice, Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples (fig 10a). J Clin Invest (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 4c
In order to find that dendritic cells modulate thymic egress, Invitrogen L selectin antibody (ebioscience, MEL-14) was used in flow cytometry on mouse samples (fig 4c). J Exp Med (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 3j
In order to study the role of miR-7 in acute lung injury, Invitrogen L selectin antibody (ebioscience, 12-0621-81) was used in flow cytometry on mouse samples (fig 3j). Front Immunol (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig s3i
Invitrogen L selectin antibody (eBiosciences, 12-0621-82) was used in flow cytometry on mouse samples (fig s3i). Nat Immunol (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 1d
In order to elucidate how CD4 positive T cells help regulate blood pressure, Invitrogen L selectin antibody (eBioscience, 25-0621-82) was used in flow cytometry on mouse samples (fig 1d). Nat Biotechnol (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 2a
In order to elucidate the role of Tbet in acute lung injury, Invitrogen L selectin antibody (eBioscience, Mel14) was used in flow cytometry on mouse samples (fig 2a). J Leukoc Biol (2017) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 1b
In order to investigate the contribution of TGF-beta to the eomesodermin-driven CD4 T cell program during viral infection, Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples (fig 1b). J Clin Invest (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...
In order to demonstrate that the negative regulation of T cell receptor signaling during natural killer T cell development regulates NKT1 and NKT2 differentiation and survival, Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples . J Exp Med (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig s3c
In order to investigate the role of FURIN in LysM positive myeloid cells in vivo, Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples (fig s3c). Oncotarget (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 4a
In order to implement lck-cre transgenic mice to study the role of loxP-targeted genes in T cell development and function, Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples (fig 4a). J Immunol (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 6f
In order to demonstrate that Blimp-1 controls CD4 T cell exhaustion, Invitrogen L selectin antibody (Affymetrix eBioscience, MEL-14) was used in flow cytometry on mouse samples (fig 6f). J Exp Med (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 1c
In order to use knockout mice to determine the role of cereblon in T cells, Invitrogen L selectin antibody (eBiosciences, MEL-14) was used in flow cytometry on mouse samples (fig 1c). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 5a
In order to examine the impact of emergency granulopoiesis on T and B cell function, Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples (fig 5a). J Exp Med (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 2
In order to report the effects of PD-L1 modulation of T cell function in graft-versus-host disease, Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples (fig 2). J Clin Invest (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 4
Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples (fig 4). Oncotarget (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; 1:200; loading ...; fig 1b
In order to demonstrate that Ndfip1/Ndfip2 regulate cross talk between T-cell receptor and cytokine signaling pathways, Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples at 1:200 (fig 1b). Nat Commun (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 3e
In order to identify a B cell-intrinsic mechanism by which IFN signaling promotes lupus pathogenesis, Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples (fig 3e). J Exp Med (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 1b
Invitrogen L selectin antibody (eBiosciences, MEL-14) was used in flow cytometry on mouse samples (fig 1b). Eur J Immunol (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig s3b
In order to propose that neuronal autoimmunity is a pathogenic feature of type 1 diabetes, Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples (fig s3b). Diabetes (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 7
In order to establish that autophagy is essential for maintenance of a balanced CD4 positive intestinal T cell response, Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples (fig 7). elife (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 1
Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples (fig 1). J Exp Med (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
Invitrogen L selectin antibody (eBioscience, 12-0621) was used in flow cytometry on mouse samples . Oncotarget (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; 1:300
In order to assess the role of NLRC5 to NK-T-cell crosstalk, Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples at 1:300. Nat Commun (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 5a
In order to demonstrate that control of acute infection with Trypanosoma cruzi is associated with development of systemic necrotizing vasculitis, Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples (fig 5a). Infect Immun (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; 1:100; fig s6b
In order to suggest that locally synthesized C1q promotes tumor growth, Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples at 1:100 (fig s6b). Nat Commun (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 4
Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples (fig 4). Dis Model Mech (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 3
Invitrogen L selectin antibody (eBiosciences, MEL-14) was used in flow cytometry on mouse samples (fig 3). PLoS Pathog (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 3
In order to examine the contribution of Foxo1 to activated T cells, Invitrogen L selectin antibody (eBiocience, MEL-14) was used in flow cytometry on mouse samples (fig 3). Nature (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; 1:100; fig 4, 7
In order to assess how IL-7 signaling represses TFH and Bcl-6, Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples at 1:100 (fig 4, 7). Nat Commun (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; tbl 1
In order to determine the role of G-CSF in a murine model of human uveitis-experimental autoimmune uveoretinitis, Invitrogen L selectin antibody (Invitrogen, MEL-14) was used in flow cytometry on mouse samples (tbl 1). Am J Pathol (2016) ncbi
rat monoclonal (MEL-14)
  • blocking or activating experiments; mouse; fig s7
In order to discover how macrophage burst ressponse mobilizes innate and adaptive immunity via in vivo imaging of inflammasome activation, Invitrogen L selectin antibody (ebioscience, MEL-14) was used in blocking or activating experiments on mouse samples (fig s7). Nat Med (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
Invitrogen L selectin antibody (eBioscience, 47-0621-80) was used in flow cytometry on mouse samples . Sci Rep (2015) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 2c
In order to study the effects of IFN signaling on neutrophil polarization, Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples (fig 2c). Int J Cancer (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 2
Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples (fig 2). J Immunol (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig s3
Invitrogen L selectin antibody (eBioscience, 56-0621) was used in flow cytometry on mouse samples (fig s3). Leukemia (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 4
In order to study murine nasal passages to identify and analyze natural killer cells, Invitrogen L selectin antibody (eBiosciences, MEL-14) was used in flow cytometry on mouse samples (fig 4). PLoS ONE (2015) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
In order to explore the impact of chronic antigenic stimulation on CD4(+) T cell dynamics, Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples . J Immunol (2015) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 3
Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples (fig 3). Oncotarget (2015) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 3c
In order to report a role for effector T helper type 2 cells during T cell receptor-independent innate-like immune responses, Invitrogen L selectin antibody (eBiosciences, MEL-14) was used in flow cytometry on mouse samples (fig 3c). Nat Immunol (2015) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
In order to study PI3Kdelta in CD8+ T cells during infection with Listeria monocytogenes, Invitrogen L selectin antibody (Caltag Laboratories, MEL-14) was used in flow cytometry on mouse samples . J Immunol (2015) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 4
Invitrogen L selectin antibody (eBiosciences, MEL-14) was used in flow cytometry on mouse samples (fig 4). Nat Immunol (2015) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 2e
In order to assess surface expression of C-type lectin-like receptor 2 on hematopoietic cells from peripheral blood and secondary lymphoid organs, Invitrogen L selectin antibody (eBiosciences, MEL-14) was used in flow cytometry on mouse samples (fig 2e). Eur J Immunol (2015) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig s1
Invitrogen L selectin antibody (eBioscience, MEL14) was used in flow cytometry on mouse samples (fig s1). Nat Commun (2015) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 2
Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples (fig 2). Immunity (2015) ncbi
rat monoclonal (MEL-14)
  • immunohistochemistry - paraffin section; human; fig s8
In order to describe the use of CCR9 expression to create primary gastrointestinal tumors in immunodeficient mice by tail-vein injection, Invitrogen L selectin antibody (ebiosciences, MEL-14) was used in immunohistochemistry - paraffin section on human samples (fig s8). Nat Biotechnol (2015) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 3
Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples (fig 3). Nat Immunol (2015) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 5a
In order to assess a CD 4 T-cell population during tuberculosis that has memory-like properties maintained by Bcl6 and ICOS-dependent pathways, Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples (fig 5a). J Exp Med (2015) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; 1:1000; fig 4
Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples at 1:1000 (fig 4). Nat Commun (2015) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig s1e
Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples (fig s1e). PLoS ONE (2015) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples . FASEB J (2015) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig s7
Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples (fig s7). Nat Immunol (2015) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples . Eur J Immunol (2015) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 2
In order to show that the PTEN-mTORC2 axis maintains T regulatory cell stability and coordinates their control of effector responses, Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples (fig 2). Nat Immunol (2015) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
In order to identify Cd8 cis-regulatory elements, Invitrogen L selectin antibody (eBioscience, MEL14) was used in flow cytometry on mouse samples . J Leukoc Biol (2015) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig s2
Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples (fig s2). J Immunol (2015) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 5a
In order to investigate the role of Jmjd3 in T-cell differentiation, Invitrogen L selectin antibody (ebioscience, 11-0621-85) was used in flow cytometry on mouse samples (fig 5a). Nat Commun (2014) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
In order to characterize high zone tolerance in mouse models of type I allergy and of allergic airway inflammation, Invitrogen L selectin antibody (Caltag, clone MEL-14) was used in flow cytometry on mouse samples . Immunobiology (2015) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
In order to examine the role of lymph node stromal cells in immune responses, Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples . elife (2014) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 2a
In order to investigate the role of DUSP6 in colonic CD4 positive T-cell function, differentiation, and inflammatory profile, Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples (fig 2a). Mucosal Immunol (2015) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; 1:200
Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples at 1:200. Nat Commun (2014) ncbi
rat monoclonal (MEL-14)
  • immunocytochemistry; mouse
Invitrogen L selectin antibody (eBioscience, MEL-14) was used in immunocytochemistry on mouse samples . J Immunol (2014) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples . Proc Natl Acad Sci U S A (2014) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples . J Virol (2014) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples . Cancer Res (2014) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
In order to investigate the role of thoracic thymus in T cell development and homeostasis, Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples . Eur J Immunol (2014) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples . PLoS ONE (2014) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; 1:100
In order to study the involvement of endothelium in efficient Treg T cell recruitment in vivo, Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples at 1:100. Nat Commun (2014) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; tbl 1
In order to study the effect of innate lymphoid cells on B cells, Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples (tbl 1). Nat Immunol (2014) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig s2
In order to use a mouse model to examine the link between the microbiota and atopic dermatitis, Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples (fig s2). J Invest Dermatol (2013) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
In order to study the impact of mesenchymal stem cells to experimental allergic encephalomyelitis, Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples . Front Immunol (2013) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
In order to elucidate how TGF-beta signaling regulates the self-reactivity of peripheral T cells, Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples . Nat Immunol (2012) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
In order to suggest that CD80 and CD86 contribute to polyclonal B cell activation mediated by Lat(Y136F) CD4 positive T cells, Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples . Front Immunol (2012) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 1
In order to test the ability of different types of antigen presenting cells to induce a CD8(+) T cell response, Invitrogen L selectin antibody (Caltag, MEL-14) was used in flow cytometry on mouse samples (fig 1). PLoS ONE (2012) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 1
In order to examine how IL-27 influences Tregs in vivo, Invitrogen L selectin antibody (Invitrogen, MEL-14) was used in flow cytometry on mouse samples (fig 1). J Immunol (2011) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
In order to determine the reconstitution capacity of transferred isolated naive CD8+ T cells, Invitrogen L selectin antibody (Caltag, MEL14) was used in flow cytometry on mouse samples . PLoS ONE (2011) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 5
In order to generate and characterize Id3 conditional T cell knock out mice, Invitrogen L selectin antibody (eBioscience, 17-0621) was used in flow cytometry on mouse samples (fig 5). Immunol Lett (2011) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 2, 3
In order to report sex-dependent, B7-H1-dependent differences in tumor immunity, Invitrogen L selectin antibody (eBioscience, MEL14) was used in flow cytometry on mouse samples (fig 2, 3). J Immunol (2010) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 1
In order to investigate the different immune responses when mice are infected with type I or type II strains of T. gondii, Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples (fig 1). J Immunol (2010) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 2
In order to use a murine diet-induced obesity model to study the kinetics of metabolic and inflammatory factors, Invitrogen L selectin antibody (Invitrogen, MEL-14) was used in flow cytometry on mouse samples (fig 2). PPAR Res (2010) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 1
In order to elucidate the role of AUF1 in the immune system, Invitrogen L selectin antibody (Caltag, MEL-14) was used in flow cytometry on mouse samples (fig 1). BMC Immunol (2010) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples . J Immunol (2009) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 2
Invitrogen L selectin antibody (eBiosciences, MEL-14) was used in flow cytometry on mouse samples (fig 2). J Immunol (2009) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
In order to elucidate the role of IL-17 in influenza A infection, Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples . J Immunol (2009) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig s1
In order to report the potency of a simple needle-free, mucosal vaccination, Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples (fig s1). J Immunol (2009) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig s2
Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples (fig s2). Proc Natl Acad Sci U S A (2009) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 2
In order to report that Ly49D engagement on T cells leads to T cell activation and TCR-independent effector functions of CD8 T cells, Invitrogen L selectin antibody (eBioscience, MEL14) was used in flow cytometry on mouse samples (fig 2). J Immunol (2009) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 5
In order to study VSV-vectored vaccines, Invitrogen L selectin antibody (Invitrogen, clone MEL-14) was used in flow cytometry on mouse samples (fig 5). Vaccine (2009) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 5
In order to identify key signals required for the exponential expansion of specific CD8 positive mouse T cells in vivo, Invitrogen L selectin antibody (Caltag, MEL-14) was used in flow cytometry on mouse samples (fig 5). J Immunol (2008) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
In order to elucidate whether UVB exposure inhibits the expansion of effector CD4+ and CD8+ T cells in skin-draining lymph nodes and reduces the number of CD4+ and IFN-gamma+ CD8+ T cells at sites of challenge, Invitrogen L selectin antibody (eBiosciences, MEL-14) was used in flow cytometry on mouse samples . Am J Pathol (2008) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
In order to analyze protection against Plasmodium berghei by a single-dose simian adenovirus vector using a human cytomegalovirus promoter containing intron A, Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples . J Virol (2008) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 1
In order to investigate the effect of Stat6 in T cell expansion, survival, and recruitment to the lung, Invitrogen L selectin antibody (Caltag, MEL-14) was used in flow cytometry on mouse samples (fig 1). J Immunol (2008) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
In order to test the influences of IL-21 on cytokine receptor expression, Invitrogen L selectin antibody (Caltag, MEL-14) was used in flow cytometry on mouse samples . Eur J Immunol (2007) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
In order to study the strength and duration of an antigenic signal at initial stimulation and the development and response of effectors and memory cells to secondary stimulation with the same antigen, Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples . Immunology (2008) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
In order to demonstrate that cerebral malaria development is independent of TLR2, 4 and 9, Invitrogen L selectin antibody (Caltag, MEL-14) was used in flow cytometry on mouse samples . Med Microbiol Immunol (2008) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; tbl 1
In order to elucidate the role of IL-10 in regulating hepatic injury using IL-10 knockout mice infected with Trichinella spiralis, Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples (tbl 1). J Immunol (2007) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 2D
In order to discuss the development and functions of effector and memory Foxp3+ T cells, Invitrogen L selectin antibody (Invitrogen/ Life Technologies/ Caltag, MEL-14) was used in flow cytometry on mouse samples (fig 2D). J Immunol (2007) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
In order to study the migration and persistence of naive, effector, and rested effector CD4+ T cells generated in vitro following transfer to nonimmunized adoptive hosts, Invitrogen L selectin antibody (Caltag, Mel 14) was used in flow cytometry on mouse samples . J Biol Chem (2007) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
In order to evaluate the use of biodegradable poly(D,L-lactic-co-glycolic acid) nanoparticles as a vaccine delivery system, Invitrogen L selectin antibody (E-Bioscience, MEL-14) was used in flow cytometry on mouse samples . J Biomed Mater Res A (2007) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 3
In order to assess how FTY720-treatment affects T cell populations, Invitrogen L selectin antibody (Caltag, Mel-14) was used in flow cytometry on mouse samples (fig 3). Int Immunopharmacol (2006) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
In order to demonstrate that software designed for transcriptomics applications can be used in multiparameter flow cytometry, Invitrogen L selectin antibody (Caltag, Mel-14) was used in flow cytometry on mouse samples . Cytometry A (2006) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; human
In order to discuss how a polymorphism in exon 4 of CD45 contributes to autoimmune and infectious diseases in humans, Invitrogen L selectin antibody (Caltag, Mel-14) was used in flow cytometry on human samples . J Med Genet (2006) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
In order to evaluate the tuberculosis vaccine candidate Mtb72F, Invitrogen L selectin antibody (eBiosciences, MEL-14) was used in flow cytometry on mouse samples . Infect Immun (2005) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
In order to test if IgE antibodies modulate T helper cells in vivo, Invitrogen L selectin antibody (Caltag, MEL-14) was used in flow cytometry on mouse samples . J Immunol (2005) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 1
Invitrogen L selectin antibody (eBioscience, MEL14) was used in flow cytometry on mouse samples (fig 1). J Immunol (2005) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 3
In order to show that the decrease in T regulatory cell activity in collagen-induced arthritis is counter-regulated by endogenous IFN-gamma, Invitrogen L selectin antibody (CALTAG Laboratories, MEL-14) was used in flow cytometry on mouse samples (fig 3). Arthritis Res Ther (2005) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 4A
In order to test if a pre-existing antigen-specific Th1 response affect the development of Th2 cells in vivo, Invitrogen L selectin antibody (eBioscience, MEL-14) was used in flow cytometry on mouse samples (fig 4A). J Immunol (2005) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
In order to study mycobacterial dissemination and immune-cell trafficking in tuberculosis, Invitrogen L selectin antibody (Caltag, MEL-14) was used in flow cytometry on mouse samples . J Infect Dis (2004) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 5
In order to investigate how Trypanosoma cruzi infection results in T cell unresponsiveness, Invitrogen L selectin antibody (Biosource, Mel14) was used in flow cytometry on mouse samples (fig 5). Int Immunol (2004) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
In order to characterize transgenic mice that express the high and low molecular weight CD45 isoforms, Invitrogen L selectin antibody (Caltag, MEL-14) was used in flow cytometry on mouse samples . Int Immunol (2004) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
In order to test if CD4 regulatory cells prevent autologous graft-vs.-host disease, Invitrogen L selectin antibody (Caltag, MEL-14) was used in flow cytometry on mouse samples . Am J Transplant (2004) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 6
In order to characterize a new mouse model of rheumatoid arthritis, Invitrogen L selectin antibody (Caltag, MEL14) was used in flow cytometry on mouse samples (fig 6). Int Immunol (2004) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 1
In order to test if higher numbers of hematopoietic stem cells correlate with the speed of immune reconstitution in a congenic transplantation mouse model, Invitrogen L selectin antibody (Caltag, MEL-14) was used in flow cytometry on mouse samples (fig 1). Blood (2004) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 5
In order to study the contribution of BAFF to apoptosis and differentiation in B cells, Invitrogen L selectin antibody (Caltag, MEL 14) was used in flow cytometry on mouse samples (fig 5). Eur J Immunol (2004) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
In order to identify cellular mechanisms that contribute to susceptibility/resistance to tuberculosis, Invitrogen L selectin antibody (Caltag, MEL-14) was used in flow cytometry on mouse samples . Clin Exp Immunol (2004) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 2
In order to track the dynamics of the antiviral CD8+ T cell responses using a transgenic mouse that marks activated T cells, Invitrogen L selectin antibody (Caltag, MEL-14) was used in flow cytometry on mouse samples (fig 2). J Immunol (2003) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
In order to examine interactions between alloreactive CD4 and CD8 T cells in mixed lymphocyte reactions and in the graft-versus-host reaction, Invitrogen L selectin antibody (Caltag, MEL-14) was used in flow cytometry on mouse samples . Immunology (2003) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 4
In order to investigate the role of MHC class II transactivator in T cell differentiation, Invitrogen L selectin antibody (Caltag, Mel14) was used in flow cytometry on mouse samples (fig 4). J Immunol (2003) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
In order to investigate how all-trans retinoic acid enhances Th2 development, Invitrogen L selectin antibody (Caltag, Mel-14 RPE) was used in flow cytometry on mouse samples . J Nutr (2002) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 4, 5
In order to study loss of CD8+ cells in IL-15Ralpha(-/-) mice, Invitrogen L selectin antibody (CALTAG, MEL-14) was used in flow cytometry on mouse samples (fig 4, 5). J Immunol (2002) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 1
In order to determine the role of CD69 in thymocyte development, Invitrogen L selectin antibody (Caltag, MEL-14) was used in flow cytometry on mouse samples (fig 1). J Immunol (2002) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
In order to elucidate the roles of BAFF and APRIL in B cell development, Invitrogen L selectin antibody (Caltag, MEL-14) was used in flow cytometry on mouse samples . J Exp Med (2001) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 4
In order to report a specialized B helper and tissue inflammatory CD4(+) T cell subset, Invitrogen L selectin antibody (Caltag, clone MEL-14) was used in flow cytometry on mouse samples (fig 4). Nat Immunol (2001) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
In order to study the cell cycle using FADD(-/-) peripheral T cells, Invitrogen L selectin antibody (Caltag, MEL-14) was used in flow cytometry on mouse samples . J Biol Chem (2001) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 1
In order to characterize murine tumor-infiltrating lymphocytes, Invitrogen L selectin antibody (CalTag, MEL 14) was used in flow cytometry on mouse samples (fig 1). J Immunol (2001) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
In order to determine the signaling duration requirements for priming and clonal expansion of naive cytotoxic T lymphocytes, Invitrogen L selectin antibody (Caltag, clone MEL14) was used in flow cytometry on mouse samples . Nat Immunol (2001) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 2
In order to report that the lymphoid environment limits T cell proliferation in response to high superantigen levels, Invitrogen L selectin antibody (Caltag, Mel-14) was used in flow cytometry on mouse samples (fig 2). Eur J Immunol (2001) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 5
In order to report that histone deacetylase inhibitors alter the acetylation of histones and enhance the expression of several genes on tumor cells, Invitrogen L selectin antibody (Caltag, MEL-14) was used in flow cytometry on mouse samples (fig 5). J Immunol (2000) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 1
In order to investigate how antigen exposure affects T cell proliferation and cell death, Invitrogen L selectin antibody (Caltag, Mel 14) was used in flow cytometry on mouse samples (fig 1). J Immunol (2000) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 2
In order to elucidate the unique and overlapping functions of LFA-1 and Mac-1, Invitrogen L selectin antibody (CalTag, MEL-14) was used in flow cytometry on mouse samples (fig 2). J Immunol (1999) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
In order to identify cells that mediate positive selection of CD8(+) T cells, Invitrogen L selectin antibody (Caltag, MEL-14) was used in flow cytometry on mouse samples . Proc Natl Acad Sci U S A (1999) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 1
In order to identify two types of NKT cells based on their reactivity to CD1d, Invitrogen L selectin antibody (Caltag, Mel-14) was used in flow cytometry on mouse samples (fig 1). J Immunol (1999) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
In order to study the migration of T cell subsets in mice with autoimmune gastritis, Invitrogen L selectin antibody (Caltag, MEL-14) was used in flow cytometry on mouse samples . Int Immunol (1998) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
In order to identify the initial source of IL-4 in early immune responses, Invitrogen L selectin antibody (Caltag, Mel-14) was used in flow cytometry on mouse samples . Int Immunol (1998) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
In order to test if peptide IAbeta134-148 inhibits antigen-induced T cell tolerance, Invitrogen L selectin antibody (Caltag, MEL-14) was used in flow cytometry on mouse samples . Int Immunol (1998) ncbi
rat monoclonal (MEL-14)
  • blocking or activating experiments; mouse
  • flow cytometry; mouse; fig 3
In order to assess the role of L-selectin in the pathogenesis of autoimmune diabetes, Invitrogen L selectin antibody (caltag, Mel-14) was used in blocking or activating experiments on mouse samples and in flow cytometry on mouse samples (fig 3). Eur J Immunol (1995) ncbi
rat monoclonal (MEL-14)
  • blocking or activating experiments; mouse; 80 ug/mouse
In order to observe leukocyte rolling after tissue trauma, Invitrogen L selectin antibody (noco, MEL-14) was used in blocking or activating experiments on mouse samples at 80 ug/mouse. J Exp Med (1995) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 1
In order to show the involvement of the MEL-14 antigen in neutrophil-endothelial cell interactions, Invitrogen L selectin antibody (noco, MEL-14) was used in flow cytometry on mouse samples (fig 1). J Immunol (1987) ncbi
rat monoclonal (MEL-14)
  • blocking or activating experiments; mouse
  • flow cytometry; mouse
  • immunoprecipitation; mouse
In order to study localization of lymph node homing receptor core polypeptide to Chromosome 1, Invitrogen L selectin antibody (noco, MEL-14) was used in blocking or activating experiments on mouse samples , in flow cytometry on mouse samples and in immunoprecipitation on mouse samples . Cell (1990) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
In order to investigate thymocyte emigration, Invitrogen L selectin antibody (Caltag, Mel-14) was used in flow cytometry on mouse samples . Eur J Immunol (1991) ncbi
BioLegend
rat monoclonal (MEL-14)
  • flow cytometry; mouse; 1:100; loading ...; fig s7-1d
BioLegend L selectin antibody (Biolegend, 104420) was used in flow cytometry on mouse samples at 1:100 (fig s7-1d). elife (2022) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 4f
BioLegend L selectin antibody (Biolegend, MEL-14) was used in flow cytometry on mouse samples (fig 4f). Front Cell Infect Microbiol (2022) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; 1:300; fig 6k
BioLegend L selectin antibody (Biolegend, 104428) was used in flow cytometry on mouse samples at 1:300 (fig 6k). PLoS Biol (2022) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 2a
BioLegend L selectin antibody (BioLegend, 104408) was used in flow cytometry on mouse samples (fig 2a). Sci Adv (2022) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 4d
BioLegend L selectin antibody (Biolegend, 104427) was used in flow cytometry on mouse samples (fig 4d). iScience (2022) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; 1:100; fig 1g
BioLegend L selectin antibody (BioLegend, MEL-14) was used in flow cytometry on mouse samples at 1:100 (fig 1g). Nat Commun (2022) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 2c, 3d
BioLegend L selectin antibody (BioLegend, MEL-14) was used in flow cytometry on mouse samples (fig 2c, 3d). Int J Mol Sci (2022) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 2g
BioLegend L selectin antibody (Biolegend, MEL-14) was used in flow cytometry on mouse samples (fig 2g). JCI Insight (2022) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 5a, s8g
BioLegend L selectin antibody (BioLegend, 104406) was used in flow cytometry on mouse samples (fig 5a, s8g). J Clin Invest (2022) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 2a
BioLegend L selectin antibody (BioLegend, 104424) was used in flow cytometry on mouse samples (fig 2a). Int J Mol Sci (2021) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; human; loading ...; fig s3a
BioLegend L selectin antibody (BioLegend, MEL-14) was used in flow cytometry on human samples (fig s3a). Front Immunol (2021) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 3a
BioLegend L selectin antibody (BioLegend, MEL-14) was used in flow cytometry on mouse samples (fig 3a). Commun Biol (2021) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; 1:200
BioLegend L selectin antibody (BioLegend, 104405) was used in flow cytometry on mouse samples at 1:200. Nat Commun (2021) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; 1:300; loading ...; fig 3c
BioLegend L selectin antibody (Biolegend, MEL-14) was used in flow cytometry on mouse samples at 1:300 (fig 3c). Nat Commun (2021) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...
BioLegend L selectin antibody (BioLegend, MEL-14) was used in flow cytometry on mouse samples . Am J Physiol Endocrinol Metab (2021) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; 1:200; loading ...; fig 3i
BioLegend L selectin antibody (BioLegend, MEL-14) was used in flow cytometry on mouse samples at 1:200 (fig 3i). Cancer Res (2021) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 2c
BioLegend L selectin antibody (Biolegend, MEL-14) was used in flow cytometry on mouse samples (fig 2c). Adv Sci (Weinh) (2021) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; 1:100; loading ...; fig s5-1g
BioLegend L selectin antibody (BioLegend, 104432) was used in flow cytometry on mouse samples at 1:100 (fig s5-1g). elife (2021) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; 1:100; loading ...; fig s22a
BioLegend L selectin antibody (Biolegend, MEL-14) was used in flow cytometry on mouse samples at 1:100 (fig s22a). Nat Commun (2021) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 6a
BioLegend L selectin antibody (BioLegend, MEL-14) was used in flow cytometry on mouse samples (fig 6a). Front Immunol (2021) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig s2b
BioLegend L selectin antibody (Biolegend, 104418) was used in flow cytometry on mouse samples (fig s2b). J Clin Invest (2021) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 5d
BioLegend L selectin antibody (BioLegend, MEL-14) was used in flow cytometry on mouse samples (fig 5d). Adv Sci (Weinh) (2021) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; 1:100; loading ...; fig 2g
BioLegend L selectin antibody (BioLegend, 104411) was used in flow cytometry on mouse samples at 1:100 (fig 2g). elife (2021) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 10b
BioLegend L selectin antibody (BioLegend, 104410) was used in flow cytometry on mouse samples (fig 10b). Mucosal Immunol (2021) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; 1:200; fig 1b
BioLegend L selectin antibody (Biolegend, MEL-14) was used in flow cytometry on mouse samples at 1:200 (fig 1b). Front Immunol (2021) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 2c
BioLegend L selectin antibody (Biolegend, MEL-14) was used in flow cytometry on mouse samples (fig 2c). J Immunother Cancer (2021) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 1a
BioLegend L selectin antibody (Biolegend, MEL-14) was used in flow cytometry on mouse samples (fig 1a). J Autoimmun (2021) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; 1:100; fig 1a
BioLegend L selectin antibody (BioLegend, 104441) was used in flow cytometry on mouse samples at 1:100 (fig 1a). elife (2021) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; 1:200; loading ...; fig s7g
BioLegend L selectin antibody (BioLegend, MEL-14) was used in flow cytometry on mouse samples at 1:200 (fig s7g). Nat Immunol (2021) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; 1:200; loading ...
BioLegend L selectin antibody (Biolegend, 104418) was used in flow cytometry on mouse samples at 1:200. Nature (2021) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 2e
BioLegend L selectin antibody (Biolegend, MEL-14) was used in flow cytometry on mouse samples (fig 2e). Antioxidants (Basel) (2020) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; 1:200; loading ...; fig 3b
BioLegend L selectin antibody (BioLegend, MEL-14) was used in flow cytometry on mouse samples at 1:200 (fig 3b). elife (2020) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; 1:100; loading ...
BioLegend L selectin antibody (Biolegend, MEL-14) was used in flow cytometry on mouse samples at 1:100. elife (2020) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 2s1a
BioLegend L selectin antibody (Biolegend, 104427) was used in flow cytometry on mouse samples (fig 2s1a). elife (2020) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; 1:1000; loading ...; fig 2s1b
BioLegend L selectin antibody (BioLegend, 104418) was used in flow cytometry on mouse samples at 1:1000 (fig 2s1b). elife (2020) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 2d
BioLegend L selectin antibody (BioLegend, MEL-14) was used in flow cytometry on mouse samples (fig 2d). Adv Sci (Weinh) (2020) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 5d
BioLegend L selectin antibody (BioLegend, MEL-14) was used in flow cytometry on mouse samples (fig 5d). Nat Commun (2020) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...
BioLegend L selectin antibody (Biolegend, MEL-14) was used in flow cytometry on mouse samples . BMC Immunol (2020) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig s18
BioLegend L selectin antibody (BioLegend, MEL-14) was used in flow cytometry on mouse samples (fig s18). Nat Commun (2020) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 1b
BioLegend L selectin antibody (Biolegend, MEL-14) was used in flow cytometry on mouse samples (fig 1b). BMC Biol (2020) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 1c
BioLegend L selectin antibody (Biolegend, 104412) was used in flow cytometry on mouse samples (fig 1c). Cell Rep (2020) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 1c
BioLegend L selectin antibody (BioLegend, MEL-14) was used in flow cytometry on mouse samples (fig 1c). elife (2020) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; 1:200; loading ...; fig 1a, 2a
BioLegend L selectin antibody (Biolegend, 104411) was used in flow cytometry on mouse samples at 1:200 (fig 1a, 2a). Nat Commun (2020) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 1e, 1j
BioLegend L selectin antibody (BioLegend, MEL-14) was used in flow cytometry on mouse samples (fig 1e, 1j). Sci Adv (2020) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig s1a
BioLegend L selectin antibody (Biolegend, MEL-14) was used in flow cytometry on mouse samples (fig s1a). Aging (Albany NY) (2020) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; 1:100; loading ...; fig 3a, 3b
BioLegend L selectin antibody (Biolegend, 104443) was used in flow cytometry on mouse samples at 1:100 (fig 3a, 3b). Nat Commun (2020) ncbi
rat monoclonal (MEL-14)
  • mass cytometry; mouse; 3.5 ug/ml; loading ...; fig 5d
BioLegend L selectin antibody (Biolegend, MEL-14) was used in mass cytometry on mouse samples at 3.5 ug/ml (fig 5d). Science (2019) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 3
BioLegend L selectin antibody (Bio-Legend, MEL-14) was used in flow cytometry on mouse samples (fig 3). BMC Infect Dis (2019) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig s1c
BioLegend L selectin antibody (Biolegend, 104441) was used in flow cytometry on mouse samples (fig s1c). Cell Rep (2019) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 2f, s3n
BioLegend L selectin antibody (BioLegend, MEL-14) was used in flow cytometry on mouse samples (fig 2f, s3n). Science (2019) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig e2a
BioLegend L selectin antibody (BioLegend, MEL-14) was used in flow cytometry on mouse samples (fig e2a). Nature (2019) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; 1:100; loading ...; fig 8a
BioLegend L selectin antibody (Biolegend, 104438) was used in flow cytometry on mouse samples at 1:100 (fig 8a). elife (2019) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig s1h
BioLegend L selectin antibody (Biolegend, MEL-14) was used in flow cytometry on mouse samples (fig s1h). Science (2019) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 3a
BioLegend L selectin antibody (BioLegend, Mel-14) was used in flow cytometry on mouse samples (fig 3a). Aging (Albany NY) (2019) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 1a
BioLegend L selectin antibody (BioLegend, MEL-14) was used in flow cytometry on mouse samples (fig 1a). J Clin Invest (2019) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig s1c
BioLegend L selectin antibody (BioLegend, 104443) was used in flow cytometry on mouse samples (fig s1c). Cell (2019) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig s3e
BioLegend L selectin antibody (Biolegend, MEL-14) was used in flow cytometry on mouse samples (fig s3e). JCI Insight (2019) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 4
BioLegend L selectin antibody (BioLegend, MEL-14) was used in flow cytometry on mouse samples (fig 4). J Immunol (2019) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; 1:120; loading ...; fig 1a
BioLegend L selectin antibody (Biolegend, MEL-14) was used in flow cytometry on mouse samples at 1:120 (fig 1a). elife (2019) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig ex3b
BioLegend L selectin antibody (BioLegend, MEL-14) was used in flow cytometry on mouse samples (fig ex3b). Nature (2019) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 5a
BioLegend L selectin antibody (BioLegend, MEL-14) was used in flow cytometry on mouse samples (fig 5a). J Exp Med (2019) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig s2e
BioLegend L selectin antibody (BioLegend, MEL-14) was used in flow cytometry on mouse samples (fig s2e). Nature (2019) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 4b
BioLegend L selectin antibody (Biolegend, MEL-14) was used in flow cytometry on mouse samples (fig 4b). Cell Rep (2019) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; 1:100; loading ...; fig 1b
BioLegend L selectin antibody (Biolegend, 104417) was used in flow cytometry on mouse samples at 1:100 (fig 1b). Nat Commun (2019) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 3c
BioLegend L selectin antibody (Biolegend, 104407) was used in flow cytometry on mouse samples (fig 3c). Cell Rep (2019) ncbi
mouse monoclonal (OX-85)
  • flow cytometry; rat; loading ...; fig s1j
BioLegend L selectin antibody (Biolegend, OX-85) was used in flow cytometry on rat samples (fig s1j). Nature (2019) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; 1:200; loading ...; fig 2a
BioLegend L selectin antibody (BioLegend, 104407) was used in flow cytometry on mouse samples at 1:200 (fig 2a). Sci Adv (2019) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 4c
BioLegend L selectin antibody (BioLegend, MEL-14) was used in flow cytometry on mouse samples (fig 4c). J Immunol (2019) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig e1b
BioLegend L selectin antibody (Biolegend, MEL-14) was used in flow cytometry on mouse samples (fig e1b). Nature (2019) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig s1k
BioLegend L selectin antibody (Biolegend, 104408) was used in flow cytometry on mouse samples (fig s1k). Cell Rep (2018) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 2b
BioLegend L selectin antibody (Biolegend, 104445) was used in flow cytometry on mouse samples (fig 2b). Cell Rep (2018) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig s5d
BioLegend L selectin antibody (BioLegend, MEL-14) was used in flow cytometry on mouse samples (fig s5d). JCI Insight (2018) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 1c
BioLegend L selectin antibody (BioLegend, MEL-14) was used in flow cytometry on mouse samples (fig 1c). J Exp Med (2018) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 2b, 5c
BioLegend L selectin antibody (BioLegend, MEL-14) was used in flow cytometry on mouse samples (fig 2b, 5c). J Clin Invest (2018) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 2a
BioLegend L selectin antibody (BioLegend, MEL-14) was used in flow cytometry on mouse samples (fig 2a). J Clin Invest (2019) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 1c
BioLegend L selectin antibody (BioLegend, Mel-14) was used in flow cytometry on mouse samples (fig 1c). J Clin Invest (2018) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 6a
BioLegend L selectin antibody (BioLegend, MEL-14) was used in flow cytometry on mouse samples (fig 6a). J Exp Med (2018) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 1b
BioLegend L selectin antibody (BioLegend, MEL-14) was used in flow cytometry on mouse samples (fig 1b). Circulation (2018) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig s2j
BioLegend L selectin antibody (BioLegend, MEL-14) was used in flow cytometry on mouse samples (fig s2j). Science (2018) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; 1:150; loading ...; fig s3a
BioLegend L selectin antibody (BioLegend, 104408) was used in flow cytometry on mouse samples at 1:150 (fig s3a). Nat Commun (2018) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 2e
BioLegend L selectin antibody (BioLegend, MEL-14) was used in flow cytometry on mouse samples (fig 2e). J Virol (2018) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; 1:100; loading ...; fig 4e
BioLegend L selectin antibody (BioLegend, MEL-14) was used in flow cytometry on mouse samples at 1:100 (fig 4e). Nat Immunol (2018) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 3a
BioLegend L selectin antibody (BioLegend, MEL-14) was used in flow cytometry on mouse samples (fig 3a). Oncoimmunology (2018) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 5f
BioLegend L selectin antibody (Biolegend, MEL-14) was used in flow cytometry on mouse samples (fig 5f). Nat Immunol (2018) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 1d
BioLegend L selectin antibody (BioLegend, MEL-14) was used in flow cytometry on mouse samples (fig 1d). J Immunol (2018) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig s1f
BioLegend L selectin antibody (Biolegend, 104405) was used in flow cytometry on mouse samples (fig s1f). Immunity (2017) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 4c
BioLegend L selectin antibody (BioLegend, MEL-14) was used in flow cytometry on mouse samples (fig 4c). Front Immunol (2017) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; 1:100; loading ...; fig 2b
BioLegend L selectin antibody (BioLegend, MEL-14) was used in flow cytometry on mouse samples at 1:100 (fig 2b). Nat Commun (2017) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...
In order to evaluate mouse models of hepacivirus infection, BioLegend L selectin antibody (Biolegend, MEL-14) was used in flow cytometry on mouse samples . Science (2017) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 3b
In order to study the involvement of the Ox40/Ox40 ligand pathway in systemic lupus erythematosus, BioLegend L selectin antibody (BioLegend, 104432) was used in flow cytometry on mouse samples (fig 3b). J Immunol (2017) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig s1d
BioLegend L selectin antibody (BioLegend, MEL-14) was used in flow cytometry on mouse samples (fig s1d). Cell Death Differ (2017) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; 1:400; loading ...; fig s3b
BioLegend L selectin antibody (Biolegend, MEL-14) was used in flow cytometry on mouse samples at 1:400 (fig s3b). Nat Commun (2017) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 1c
In order to investigate the effect of lymphatic endothelial S1P on mitochondrial function and naive T cell survival, BioLegend L selectin antibody (Biolegend, MEL14) was used in flow cytometry on mouse samples (fig 1c). Nature (2017) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig s3a
BioLegend L selectin antibody (Biolegend, MEL-14) was used in flow cytometry on mouse samples (fig s3a). Nature (2017) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 7g
BioLegend L selectin antibody (BioLegend, MEL-14) was used in flow cytometry on mouse samples (fig 7g). J Exp Med (2017) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
In order to study the involvement of endocannabinoid system in intestinal immune homeostasis, BioLegend L selectin antibody (Biolegend, ME2-14) was used in flow cytometry on mouse samples . Proc Natl Acad Sci U S A (2017) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 1c
BioLegend L selectin antibody (BioLegend, MEL-14) was used in flow cytometry on mouse samples (fig 1c). J Exp Med (2017) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 3c
BioLegend L selectin antibody (Biolegend, MEL-14) was used in flow cytometry on mouse samples (fig 3c). Nat Med (2017) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 1b
In order to explore how the different Fcgamma receptors expressed on dendritic cells affect the initiation of T cell responses, BioLegend L selectin antibody (biolegend, MEL-14) was used in flow cytometry on mouse samples (fig 1b). J Exp Med (2017) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig s8a
In order to investigate how aging affects transcriptional dynamics in naive and CD4 positive T cells, BioLegend L selectin antibody (BioLegend, MEL-14) was used in flow cytometry on mouse samples (fig s8a). Science (2017) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 1b
BioLegend L selectin antibody (BioLegend, MEL-14) was used in flow cytometry on mouse samples (fig 1b). Front Immunol (2017) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 5b
In order to find that TLR3, 7 and 9 deficiencies on host cells result in complete tumor regression and induction of anti-tumor immunity, BioLegend L selectin antibody (BioLegend, Mel14) was used in flow cytometry on mouse samples (fig 5b). Nat Commun (2017) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 4b
BioLegend L selectin antibody (Biolegend, MEL-14) was used in flow cytometry on mouse samples (fig 4b). Proc Natl Acad Sci U S A (2017) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 5a
In order to examine the contribution of T-bet-expressing B cells to autoimmune diseases, BioLegend L selectin antibody (BioLegend, MEL-14) was used in flow cytometry on mouse samples (fig 5a). J Clin Invest (2017) ncbi
rat monoclonal (MEL-14)
In order to characterize mitochondrial changes in T cells due to PD-1 blockade therapy, BioLegend L selectin antibody (BioLegend, MEL-14) was used . Proc Natl Acad Sci U S A (2017) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig s6a
In order to find microenvironmental regulators of metastatic colonization, BioLegend L selectin antibody (Biolegend, MEL-14) was used in flow cytometry on mouse samples (fig s6a). Nature (2017) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig s2a
In order to elucidate how P2X7 regulates the contraction of intestinal CD4 positive effector T cells, BioLegend L selectin antibody (BioLegend, MEL-14) was used in flow cytometry on mouse samples (fig s2a). Mucosal Immunol (2017) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; 1:100; loading ...; fig 2b
BioLegend L selectin antibody (Biolegend, MEL-14) was used in flow cytometry on mouse samples at 1:100 (fig 2b). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig s1b
BioLegend L selectin antibody (BioLegend, MEL-14) was used in flow cytometry on mouse samples (fig s1b). Nat Commun (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig s1
BioLegend L selectin antibody (BioLegend, MEL14) was used in flow cytometry on mouse samples (fig s1). Science (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 6d
In order to investigate allergic responses to food allergens in WASP-deficient animals, BioLegend L selectin antibody (Biolegend, MEL-14) was used in flow cytometry on mouse samples (fig 6d). J Clin Invest (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig S2a
BioLegend L selectin antibody (BioLegend, 104405) was used in flow cytometry on mouse samples (fig S2a). J Exp Clin Cancer Res (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig s4
In order to demonstrate that OTULIN is essential for preventing TNF-associated systemic inflammation in humans and mice, BioLegend L selectin antibody (BioLegend, 104435) was used in flow cytometry on mouse samples (fig s4). Cell (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; 1:800; loading ...; tbl s2
In order to identify and characterize follicular cytotoxic T cells, BioLegend L selectin antibody (Biolegend, MEL-14) was used in flow cytometry on mouse samples at 1:800 (tbl s2). Nat Immunol (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 4a
In order to assess how ABCG1 loss in T cells affects atherosclerosis, BioLegend L selectin antibody (BioLegend, MEL-14) was used in flow cytometry on mouse samples (fig 4a). J Clin Invest (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...
In order to study how IL-17 and IFN-gamma control Staphylococcus aureus infection, BioLegend L selectin antibody (BioLegend, MEL-14) was used in flow cytometry on mouse samples . Am J Pathol (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; 1:300; loading ...; fig 4f
In order to investigate the stromal contribution to the microenvironment of tumor-draining lymph nodes, BioLegend L selectin antibody (Biolegend, MEL-14) was used in flow cytometry on mouse samples at 1:300 (fig 4f). Nat Immunol (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; 1:200; fig 1
In order to study the promotion of the development of self-reactive T cells by hydrophobic CDR3 residues, BioLegend L selectin antibody (BioLegend, 104424) was used in flow cytometry on mouse samples at 1:200 (fig 1). Nat Immunol (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...
In order to investigate how dopamine receptor D3 signaling affects the balance of effector T cells, BioLegend L selectin antibody (BioLegend, MEL-14) was used in flow cytometry on mouse samples . J Immunol (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 2a
In order to investigate the mechanism for adoptively transferred effector T-cell survival and memory formation, BioLegend L selectin antibody (BioLegend, MEL-14) was used in flow cytometry on mouse samples (fig 2a). Cell Biosci (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 2
In order to study the requisite for the function of regulatory T cells known as phosphatase PP2A, BioLegend L selectin antibody (Biolegend, MEL-14) was used in flow cytometry on mouse samples (fig 2). Nat Immunol (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 2b
In order to elucidate the role of B cells in the initiation of central nervous system autoimmunity, BioLegend L selectin antibody (Biolegend, MEL-14) was used in flow cytometry on mouse samples (fig 2b). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (OX-85)
  • flow cytometry; rat
BioLegend L selectin antibody (Biolegend, OX-85) was used in flow cytometry on rat samples . Nature (2016) ncbi
rat monoclonal (MEL-14)
BioLegend L selectin antibody (Biolegend, 104428) was used . Clin Cancer Res (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
BioLegend L selectin antibody (BioLegend, 104404) was used in flow cytometry on mouse samples . PLoS ONE (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 1b
In order to show that Bhlhe40 expression marks encephalitogenic T helper cells and that the PTX-IL-1-Bhlhe40 pathway is active in mice with experimental autoimmune encephalomyelitis, BioLegend L selectin antibody (BioLegend, MEL-14) was used in flow cytometry on mouse samples (fig 1b). J Exp Med (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig s5
In order to study cessation of colorectal cancer colonization of the liver by acting on the hepatic microenvironment by IFN-alpha gene/cell therapy, BioLegend L selectin antibody (Biolegend, MEL-14) was used in flow cytometry on mouse samples (fig s5). EMBO Mol Med (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 1c
In order to study the effect of atypical protein kinase C i on asymmetric division and CD8(+) T Lymphocyte, BioLegend L selectin antibody (Biolegend, MEL-14) was used in flow cytometry on mouse samples (fig 1c). Sci Rep (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; 1:400; loading ...; fig 2f
In order to study the role of DCAF1 in T-cell function through p53-dependent and -independent mechanisms, BioLegend L selectin antibody (BioLegend, 104412) was used in flow cytometry on mouse samples at 1:400 (fig 2f). Nat Commun (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 5
BioLegend L selectin antibody (BioLegend, MEL-14) was used in flow cytometry on mouse samples (fig 5). Int J Oncol (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...
In order to elucidate the role of TfR1 in adaptive immunity, BioLegend L selectin antibody (BioLegend, MEL-14) was used in flow cytometry on mouse samples . Nat Genet (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig s2
In order to study hepatocellular carcinoma and ectopic lymphoid structures function as microniches for tumor progenitor cells, BioLegend L selectin antibody (BioLegend, 104417) was used in flow cytometry on mouse samples (fig s2). Nat Immunol (2015) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 1
In order to research skin-resident memory T cell homeostasis and lymphoma mediated by hair follicle-derived IL-7 and IL-15, BioLegend L selectin antibody (BioLegend, MEL-14) was used in flow cytometry on mouse samples (fig 1). Nat Med (2015) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig s7
BioLegend L selectin antibody (Biolegend, MEL-14) was used in flow cytometry on mouse samples (fig s7). elife (2015) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 3a
BioLegend L selectin antibody (Biolegend, MEL-14) was used in flow cytometry on mouse samples (fig 3a). Cancer Res (2015) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 2a
BioLegend L selectin antibody (Biolegend, MEL-14) was used in flow cytometry on mouse samples (fig 2a). J Immunol (2015) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 3a
BioLegend L selectin antibody (BioLegend, MEL-14) was used in flow cytometry on mouse samples (fig 3a). J Leukoc Biol (2015) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
BioLegend L selectin antibody (Biolegend, Mel-14) was used in flow cytometry on mouse samples . Eur J Immunol (2015) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
In order to elucidate the role of Treg during T. gondii infection, BioLegend L selectin antibody (Biolegend, MEL-14) was used in flow cytometry on mouse samples . Microbes Infect (2015) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
In order to report that AMPK regulates protein phosphatase activity to control the of survival and function of CD8+ T cells, thus regulating immune surveillance of tumors, BioLegend L selectin antibody (Biolegend, MEL-14) was used in flow cytometry on mouse samples . Oncotarget (2015) ncbi
rat monoclonal (MEL-14)
  • western blot; mouse; 1:100; fig 5,6
BioLegend L selectin antibody (BioLegend, Mel-14) was used in western blot on mouse samples at 1:100 (fig 5,6). Nat Commun (2015) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
BioLegend L selectin antibody (BioLegend, MEL-14) was used in flow cytometry on mouse samples . J Clin Invest (2015) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
BioLegend L selectin antibody (BioLegend, MEL-14) was used in flow cytometry on mouse samples . J Immunol (2015) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig s2
BioLegend L selectin antibody (Biolegend, MEL-14) was used in flow cytometry on mouse samples (fig s2). Brain (2015) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
BioLegend L selectin antibody (BioLegend, MEL-14) was used in flow cytometry on mouse samples . J Immunol (2015) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 1
BioLegend L selectin antibody (BioLegend, MEL14) was used in flow cytometry on mouse samples (fig 1). Toxicol Sci (2015) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
BioLegend L selectin antibody (BioLegend, MEL-14) was used in flow cytometry on mouse samples . J Clin Invest (2015) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 3a
In order to explore the interaction between IL-2 and IL-7 in CD4 T-cell memory generation, BioLegend L selectin antibody (biolegend, MEL14) was used in flow cytometry on mouse samples (fig 3a). Nat Commun (2014) ncbi
mouse monoclonal (OX-85)
  • flow cytometry; rat; fig 2
BioLegend L selectin antibody (BioLegend, OX-85) was used in flow cytometry on rat samples (fig 2). Eur J Immunol (2015) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; 1:200
BioLegend L selectin antibody (BioLegend, MEL-14) was used in flow cytometry on mouse samples at 1:200. Cancer Res (2014) ncbi
rat monoclonal (MEL-14)
BioLegend L selectin antibody (BioLegend, MEL-14) was used . J Immunol (2014) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
BioLegend L selectin antibody (BioLegend, MEL-14) was used in flow cytometry on mouse samples . J Exp Med (2014) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
In order to investigate incomplete immunity against intracellular pathogens in neonates, BioLegend L selectin antibody (Biolegend, MEL-14) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
BioLegend L selectin antibody (BioLegend, MEL14) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
Miltenyi Biotec
human monoclonal (REA828)
  • flow cytometry; mouse
Miltenyi Biotec L selectin antibody (Miltenyi Biotec, 130-112-836) was used in flow cytometry on mouse samples . iScience (2022) ncbi
rat monoclonal (MEL14-H2.100)
  • flow cytometry; mouse; loading ...; fig 2f
Miltenyi Biotec L selectin antibody (Miltenyi Biotec, MEL14-H2.100) was used in flow cytometry on mouse samples (fig 2f). Sci Immunol (2018) ncbi
rat monoclonal (MEL14-H2.100)
  • flow cytometry; mouse; loading ...; fig s1
Miltenyi Biotec L selectin antibody (Miltenyi Biotec, 130-102-907) was used in flow cytometry on mouse samples (fig s1). J Cell Mol Med (2018) ncbi
Santa Cruz Biotechnology
rat monoclonal (MECA-79)
  • immunohistochemistry - frozen section; mouse; 1:1000; loading ...; fig s1a
Santa Cruz Biotechnology L selectin antibody (Santa Cruz, sc-19602) was used in immunohistochemistry - frozen section on mouse samples at 1:1000 (fig s1a). J Clin Invest (2021) ncbi
mouse monoclonal (LAM1-116)
  • immunohistochemistry; human; 1:250
In order to study dysregulation of CD62L expression during HIV infection, Santa Cruz Biotechnology L selectin antibody (Santa, Lam1-116) was used in immunohistochemistry on human samples at 1:250. J Virol (2015) ncbi
Abcam
rat monoclonal (MEL-14)
  • immunohistochemistry - frozen section; mouse; 1:100; loading ...; fig 4c
Abcam L selectin antibody (Abcam, ab119834) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 4c). Nat Immunol (2022) ncbi
Bio-Rad
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 8
In order to study engineered anti-melanoma vaccines that modulate cytokine priming and silence PD-L1 simultaneously by use of ex vivo myeloid-derived suppressor cells as a readout of therapeutic efficacy, Bio-Rad L selectin antibody (AbD Serotec, MCA1259PE) was used in flow cytometry on mouse samples (fig 8). Oncoimmunology (2014) ncbi
Bio X Cell
rat monoclonal (MEL-14)
  • blocking or activating experiments; mouse; loading ...; fig s2a
Bio X Cell L selectin antibody (BioXcell, MEL-14) was used in blocking or activating experiments on mouse samples (fig s2a). Nature (2019) ncbi
BD Biosciences
rat monoclonal (MEL-14)
  • flow cytometry; mouse; 1:50; fig 3d
BD Biosciences L selectin antibody (BD, 560517) was used in flow cytometry on mouse samples at 1:50 (fig 3d). Cell Rep (2022) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 5e
BD Biosciences L selectin antibody (BD Pharmingen, 560516) was used in flow cytometry on mouse samples (fig 5e). Oncoimmunology (2022) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 1f
BD Biosciences L selectin antibody (BD, 553152) was used in flow cytometry on mouse samples (fig 1f). Cell Rep (2022) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 6d
BD Biosciences L selectin antibody (BD Biosciences, 560513) was used in flow cytometry on mouse samples (fig 6d). Mol Ther Oncolytics (2022) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; 1:300; loading ...; fig 7g
BD Biosciences L selectin antibody (BD Biosciences, 553151) was used in flow cytometry on mouse samples at 1:300 (fig 7g). elife (2022) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; 1:200; loading ...; fig 6j
BD Biosciences L selectin antibody (BD Biosciences, MEL-14) was used in flow cytometry on mouse samples at 1:200 (fig 6j). Sci Rep (2021) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 2b
BD Biosciences L selectin antibody (BD Pharmingen, 561918) was used in flow cytometry on mouse samples (fig 2b). Signal Transduct Target Ther (2021) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig ds1k
BD Biosciences L selectin antibody (BD, 553151) was used in flow cytometry on mouse samples (fig ds1k). Cell Rep (2021) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 10b
BD Biosciences L selectin antibody (BD Biosciences, 562404) was used in flow cytometry on mouse samples (fig 10b). Mucosal Immunol (2021) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; 1:400; loading ...; fig s8
BD Biosciences L selectin antibody (BD Pharmingen, 560516) was used in flow cytometry on mouse samples at 1:400 (fig s8). Nat Commun (2021) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...
BD Biosciences L selectin antibody (BD, MEL-14) was used in flow cytometry on mouse samples . EMBO Mol Med (2021) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...
BD Biosciences L selectin antibody (BD Biosciences, 563252) was used in flow cytometry on mouse samples . J Clin Invest (2021) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 8a
BD Biosciences L selectin antibody (BD Biosciences, MEL-14) was used in flow cytometry on mouse samples (fig 8a). Front Immunol (2020) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; 1:100; loading ...; fig 7b
BD Biosciences L selectin antibody (BD Biosciences, 553152) was used in flow cytometry on mouse samples at 1:100 (fig 7b). elife (2020) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; 1:200; loading ...
BD Biosciences L selectin antibody (BD Bioscience, MEL-14) was used in flow cytometry on mouse samples at 1:200. J Allergy Clin Immunol (2021) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 4e
BD Biosciences L selectin antibody (BD Pharmingen, Mel-14) was used in flow cytometry on mouse samples (fig 4e). elife (2020) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 6s1
BD Biosciences L selectin antibody (BD, MEL-14) was used in flow cytometry on mouse samples (fig 6s1). elife (2020) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig s5a
BD Biosciences L selectin antibody (BD Biosciences, MEL-14) was used in flow cytometry on mouse samples (fig s5a). Sci Adv (2019) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...
BD Biosciences L selectin antibody (Pharmingen, Mel-14) was used in flow cytometry on mouse samples . Front Immunol (2019) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; 1:200; fig 4e
BD Biosciences L selectin antibody (BD Biosciences, 560517) was used in flow cytometry on mouse samples at 1:200 (fig 4e). Nat Immunol (2019) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig s1a
BD Biosciences L selectin antibody (BD Biosciences, 553150) was used in flow cytometry on mouse samples (fig s1a). Cell Rep (2019) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 5a
BD Biosciences L selectin antibody (BD Biosciences, MEL-14) was used in flow cytometry on mouse samples (fig 5a). J Clin Invest (2019) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 1f
BD Biosciences L selectin antibody (BD, MEL-14) was used in flow cytometry on mouse samples (fig 1f). J Immunol (2019) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig s1a
BD Biosciences L selectin antibody (BD, MEL-14) was used in flow cytometry on mouse samples (fig s1a). Front Immunol (2018) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; 1:500; loading ...; fig 6d
BD Biosciences L selectin antibody (BD Biosciences, MEL-14) was used in flow cytometry on mouse samples at 1:500 (fig 6d). Nat Commun (2018) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig s4a
BD Biosciences L selectin antibody (BD, MEL-14) was used in flow cytometry on mouse samples (fig s4a). J Clin Invest (2019) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 3d
BD Biosciences L selectin antibody (BD, 560514) was used in flow cytometry on mouse samples (fig 3d). Cell (2018) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig s5
BD Biosciences L selectin antibody (BD Biosciences, MEL-14) was used in flow cytometry on mouse samples (fig s5). J Clin Invest (2019) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 2f
BD Biosciences L selectin antibody (BD, 553152) was used in flow cytometry on mouse samples (fig 2f). Cell (2018) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig s7d
BD Biosciences L selectin antibody (BD, MEL-14) was used in flow cytometry on mouse samples (fig s7d). Cancer Immunol Immunother (2019) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; 1:200; loading ...; fig s7d
BD Biosciences L selectin antibody (BD Biosciences, 562404) was used in flow cytometry on mouse samples at 1:200 (fig s7d). Nat Neurosci (2018) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig s17a
BD Biosciences L selectin antibody (BD Biosciences, MEL-14) was used in flow cytometry on mouse samples (fig s17a). J Clin Invest (2018) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig s2a
BD Biosciences L selectin antibody (BD Biosciences, MEL-14) was used in flow cytometry on mouse samples (fig s2a). Infect Immun (2018) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 2h
BD Biosciences L selectin antibody (BD Biosciences, 564109) was used in flow cytometry on mouse samples (fig 2h). Nat Immunol (2018) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 1e
BD Biosciences L selectin antibody (BD Biosciences, MEL-14) was used in flow cytometry on mouse samples (fig 1e). Cell Rep (2018) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 2a
BD Biosciences L selectin antibody (BD Biosciences, MEL-14) was used in flow cytometry on mouse samples (fig 2a). J Clin Invest (2018) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 5d
BD Biosciences L selectin antibody (BD Biosciences, MEL-14) was used in flow cytometry on mouse samples (fig 5d). J Clin Invest (2018) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig s6g
BD Biosciences L selectin antibody (BD Biosciences, MEL-14) was used in flow cytometry on mouse samples (fig s6g). Cell (2018) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig s4b
BD Biosciences L selectin antibody (BD Biosciences, MEL-14) was used in flow cytometry on mouse samples (fig s4b). J Immunol (2017) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 4h
In order to examine the relationships among the B cell receptor, TLR9, and cytokine signals that regulate B cell responses to DNA-containing antigens, BD Biosciences L selectin antibody (BD Biosciences, MEL-14) was used in flow cytometry on mouse samples (fig 4h). J Clin Invest (2017) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 4a
BD Biosciences L selectin antibody (BD Pharmingen, MEL-14) was used in flow cytometry on mouse samples (fig 4a). Immunology (2017) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 5d
In order to examine the localization and function of FHL2 in natural killer cells, BD Biosciences L selectin antibody (BD Biosciences, MEL-14) was used in flow cytometry on mouse samples (fig 5d). Front Immunol (2017) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 6d
In order to investigate the mechanisms by which eomesodermin regulates memory fitness in T cells, BD Biosciences L selectin antibody (BD Pharmingen, MEL-14) was used in flow cytometry on mouse samples (fig 6d). Proc Natl Acad Sci U S A (2017) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig s1b
In order to test if dermal gammadelta cells freely re-circulate out of skin, or behave like dermal resident memory T cells in mice, BD Biosciences L selectin antibody (BD PharMingen, MEL-14) was used in flow cytometry on mouse samples (fig s1b). PLoS ONE (2017) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 1d
In order to report that differentiation and self-renewal arise as opposing outcomes of sibling CD4 positive T cells during challenge with influenza, BD Biosciences L selectin antibody (BD, MEL-14) was used in flow cytometry on mouse samples (fig 1d). J Exp Med (2017) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 1a
BD Biosciences L selectin antibody (BD PharMingen, MEL-14) was used in flow cytometry on mouse samples (fig 1a). Sci Rep (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; human; loading ...; fig 3a
In order to functionally characterize herpes simplex virus-specific CD8 positive T cells, BD Biosciences L selectin antibody (BD Pharmingen, MEL-14) was used in flow cytometry on human samples (fig 3a). J Virol (2017) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig s4a
In order to explore the role of hippocampal T cell infiltration in tau-driven pathophysiology and cognitive impairments, BD Biosciences L selectin antibody (BD Biosciences, MEL-14) was used in flow cytometry on mouse samples (fig s4a). Brain (2017) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; 1:200; loading ...; fig 6c
In order to characterize malaria-induced splenic monocyte-derived dendritic cells, BD Biosciences L selectin antibody (BD Bioscience, MEL-14) was used in flow cytometry on mouse samples at 1:200 (fig 6c). Nat Commun (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig s2a
BD Biosciences L selectin antibody (BD Biosciences, 562910) was used in flow cytometry on mouse samples (fig s2a). PLoS ONE (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig s3
BD Biosciences L selectin antibody (BD, 553151) was used in flow cytometry on mouse samples (fig s3). PLoS ONE (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 1b
In order to explore signaling pathways regulated by RLTPR in T and B cells, BD Biosciences L selectin antibody (BD, MEL-14) was used in flow cytometry on mouse samples (fig 1b). J Exp Med (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
In order to investigate how organ-specific Btnl genes shape local T cell compartments, BD Biosciences L selectin antibody (BD, 560513) was used in flow cytometry on mouse samples . Cell (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 6
BD Biosciences L selectin antibody (BD Pharmingen, MEL-14) was used in flow cytometry on mouse samples (fig 6). PLoS ONE (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...
In order to demonstrate that DNMT3a directs early CD8 positive T-cell effector and memory fate decisions, BD Biosciences L selectin antibody (BD Biosciences, MEL-14) was used in flow cytometry on mouse samples . Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig s6a
BD Biosciences L selectin antibody (BD Biosciences, MEL-14) was used in flow cytometry on mouse samples (fig s6a). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
BD Biosciences L selectin antibody (BD Biosciences, 560517) was used in flow cytometry on mouse samples . Nat Commun (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; 1:100; fig 4
BD Biosciences L selectin antibody (BD Biosciences, 553150) was used in flow cytometry on mouse samples at 1:100 (fig 4). Nat Commun (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 4a
In order to discover cell-intrinsic division and differentiation differences in neonatal CD8+ T cells, BD Biosciences L selectin antibody (BD Biosciences, 562404) was used in flow cytometry on mouse samples (fig 4a). Immunol Cell Biol (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; 1:200; fig 2
BD Biosciences L selectin antibody (BD Biosciences, MEL-14) was used in flow cytometry on mouse samples at 1:200 (fig 2). Nat Immunol (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig s6
BD Biosciences L selectin antibody (BD Bioscience, 553152) was used in flow cytometry on mouse samples (fig s6). Nat Commun (2016) ncbi
rat monoclonal (MEL-14)
  • immunohistochemistry - paraffin section; mouse; fig s4
BD Biosciences L selectin antibody (BD Bioscience, 553147) was used in immunohistochemistry - paraffin section on mouse samples (fig s4). Nat Commun (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 6s
In order to compare the capacity of induced T regulatory and T helper 17 cells to develop in a T cell model of colitis, BD Biosciences L selectin antibody (BD Biosciences, MEL-14) was used in flow cytometry on mouse samples (fig 6s). J Immunol (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig s1
In order to investigate the control of LAT recruitment to the immune synapse and T-cell activation in vivo by IFT20, BD Biosciences L selectin antibody (BD, MEL-14) was used in flow cytometry on mouse samples (fig s1). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig s1
In order to study the polysialylation of CCR7, BD Biosciences L selectin antibody (BD Bioscience, MEL-14) was used in flow cytometry on mouse samples (fig s1). Science (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig s10
BD Biosciences L selectin antibody (BD Biosciences, 553150) was used in flow cytometry on mouse samples (fig s10). Nat Commun (2015) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 7
In order to study the contribution of IL-7 to pneumocystis pneumonia, BD Biosciences L selectin antibody (BD Pharmingen, 561917) was used in flow cytometry on mouse samples (fig 7). Infect Immun (2016) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 3
In order to study apolipoprotein-1 during normocholesterolemic conditions, BD Biosciences L selectin antibody (BD Pharmingen, MEL-14) was used in flow cytometry on mouse samples (fig 3). J Immunol (2015) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 3f
BD Biosciences L selectin antibody (BD Pharmingen, MEL-14) was used in flow cytometry on mouse samples (fig 3f). Eur J Immunol (2015) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 6a
BD Biosciences L selectin antibody (BD Bioscience, MEL-14) was used in flow cytometry on mouse samples (fig 6a). J Virol (2015) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 2c
In order to assess the capacity of dried microneedle array vaccination on effector/memory CD8 positive T cell subsets, BD Biosciences L selectin antibody (BD Biosciences, MEL-14) was used in flow cytometry on mouse samples (fig 2c). Vaccine (2015) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
BD Biosciences L selectin antibody (BD Pharmingen, MEL-14) was used in flow cytometry on mouse samples . J Immunol (2015) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; loading ...; fig 4
In order to show that CD4 positive T cells and ILC2s together block Nippostrongylus brasiliensis development in the parenchyma, BD Biosciences L selectin antibody (BD Biosciences, MEL-14) was used in flow cytometry on mouse samples (fig 4). Nat Commun (2015) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
BD Biosciences L selectin antibody (BD Biosciences, MEL-14) was used in flow cytometry on mouse samples . Immun Inflamm Dis (2014) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 1
BD Biosciences L selectin antibody (BD Pharmigen, MEL-14) was used in flow cytometry on mouse samples (fig 1). PLoS ONE (2015) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 7
BD Biosciences L selectin antibody (BD Pharmingen, MEL-14) was used in flow cytometry on mouse samples (fig 7). J Immunol (2015) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 6
BD Biosciences L selectin antibody (BD Pharmingen, MEL-14) was used in flow cytometry on mouse samples (fig 6). J Virol (2015) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 3
In order to report that GP96 is required for T regulatory cell maintenance and function, BD Biosciences L selectin antibody (BD Biosciences, ME-14) was used in flow cytometry on mouse samples (fig 3). J Clin Invest (2015) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
BD Biosciences L selectin antibody (BD Biosciences, MEL-14) was used in flow cytometry on mouse samples . Vaccines (Basel) (2014) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
BD Biosciences L selectin antibody (BD, MEL-14) was used in flow cytometry on mouse samples . J Immunol (2015) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 3
BD Biosciences L selectin antibody (BD, MEL-14) was used in flow cytometry on mouse samples (fig 3). Gut (2015) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 1
BD Biosciences L selectin antibody (BD PharMingen, MEL-14) was used in flow cytometry on mouse samples (fig 1). J Leukoc Biol (2015) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
BD Biosciences L selectin antibody (BD Biosciences, MEL-14) was used in flow cytometry on mouse samples . PLoS ONE (2014) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
In order to study the mechanism for the effect of HMGB1 on myeloid-derived suppressor cells, BD Biosciences L selectin antibody (BD Biosciences, MEL14) was used in flow cytometry on mouse samples . Cancer Res (2014) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
In order to study the role of CD93 molecule in mature dendritic cells and T cells, BD Biosciences L selectin antibody (BD Biosciences, MEL-14) was used in flow cytometry on mouse samples . Immunobiology (2015) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 2
In order to show that MID1 regulates cytotoxic lymphocytes responses, BD Biosciences L selectin antibody (BD Biosciences, MEL-14) was used in flow cytometry on mouse samples (fig 2). Eur J Immunol (2014) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
BD Biosciences L selectin antibody (BD Pharmingen, MEL-14) was used in flow cytometry on mouse samples . PLoS ONE (2014) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
In order to study the modulation of CD4 T-cell senescence and cytokine production and the roles played by Menin and Bach2, BD Biosciences L selectin antibody (BD Biosciences, MEL-14) was used in flow cytometry on mouse samples . Nat Commun (2014) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
BD Biosciences L selectin antibody (BD Biosciences, MEL-14) was used in flow cytometry on mouse samples . PLoS ONE (2014) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
BD Biosciences L selectin antibody (BD Biosciences, MEL-14) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse
BD Biosciences L selectin antibody (BD, MEL-14) was used in flow cytometry on mouse samples . Biochim Biophys Acta (2013) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; mouse; fig 3
BD Biosciences L selectin antibody (BD, 553151) was used in flow cytometry on mouse samples (fig 3). PLoS ONE (2013) ncbi
rat monoclonal (MEL-14)
  • flow cytometry; human
BD Biosciences L selectin antibody (BD Biosciences, 553152) was used in flow cytometry on human samples . J Immunol (2010) ncbi
Articles Reviewed
  1. Tran N, Ferreira L, Alvarez Moya B, Buttiglione V, Ferrini B, Zordan P, et al. Continuous sensing of IFNα by hepatic endothelial cells shapes a vascular antimetastatic barrier. elife. 2022;11: pubmed publisher
  2. Hou X, Shi Y, Kang X, Rousu Z, Li D, Wang M, et al. Echinococcus granulosus: The establishment of the metacestode in the liver is associated with control of the CD4+ T-cell-mediated immune response in patients with cystic echinococcosis and a mouse model. Front Cell Infect Microbiol. 2022;12:983119 pubmed publisher
  3. Smith K, Minns D, McHugh B, Holloway R, O CONNOR R, Williams A, et al. The antimicrobial peptide cathelicidin drives development of experimental autoimmune encephalomyelitis in mice by affecting Th17 differentiation. PLoS Biol. 2022;20:e3001554 pubmed publisher
  4. Que W, Ma K, Hu X, Guo W, Li X. Combinations of anti-GITR antibody and CD28 superagonist induce permanent allograft acceptance by generating type 1 regulatory T cells. Sci Adv. 2022;8:eabo4413 pubmed publisher
  5. Zhao X, Hu S, Zeng L, Liu X, Song Y, Zhang Y, et al. Irradiation combined with PD-L1-/- and autophagy inhibition enhances the antitumor effect of lung cancer via cGAS-STING-mediated T cell activation. iScience. 2022;25:104690 pubmed publisher
  6. Lu L, Li T, Feng X, Liu Z, Liu Y, Chao T, et al. Excessive immunosuppression by regulatory T cells antagonizes T cell response to schistosome infection in PD-1-deficient mice. PLoS Pathog. 2022;18:e1010596 pubmed publisher
  7. Wang Q, Bergholz J, Ding L, Lin Z, Kabraji S, Hughes M, et al. STING agonism reprograms tumor-associated macrophages and overcomes resistance to PARP inhibition in BRCA1-deficient models of breast cancer. Nat Commun. 2022;13:3022 pubmed publisher
  8. Koutn xed k J, Klepsch V, Pommermayr M, Thuille N, Baier G, Siegmund K. A MLR-Based Approach to Analyze Regulators of T Lymphocyte Activation In Vivo. Int J Mol Sci. 2022;23: pubmed publisher
  9. Taniguchi H, Caeser R, Chavan S, Zhan Y, Chow A, Manoj P, et al. WEE1 inhibition enhances the antitumor immune response to PD-L1 blockade by the concomitant activation of STING and STAT1 pathways in SCLC. Cell Rep. 2022;39:110814 pubmed publisher
  10. Melese E, Franks E, Cederberg R, Harbourne B, Shi R, Wadsworth B, et al. CCL5 production in lung cancer cells leads to an altered immune microenvironment and promotes tumor development. Oncoimmunology. 2022;11:2010905 pubmed publisher
  11. Cortes J, Filip I, Albero R, Patiño Galindo J, Quinn S, Lin W, et al. Oncogenic Vav1-Myo1f induces therapeutically targetable macrophage-rich tumor microenvironment in peripheral T cell lymphoma. Cell Rep. 2022;39:110695 pubmed publisher
  12. El Sayes N, Walsh S, Vito A, Reihani A, Ask K, Wan Y, et al. IFNAR blockade synergizes with oncolytic VSV to prevent virus-mediated PD-L1 expression and promote antitumor T cell activity. Mol Ther Oncolytics. 2022;25:16-30 pubmed publisher
  13. Fischer A, Wannemacher J, Christ S, Koopmans T, Kadri S, Zhao J, et al. Neutrophils direct preexisting matrix to initiate repair in damaged tissues. Nat Immunol. 2022;23:518-531 pubmed publisher
  14. Sibilio A, Suñer C, Fernández Alfara M, Martín J, Berenguer A, Calon A, et al. Immune translational control by CPEB4 regulates intestinal inflammation resolution and colorectal cancer development. iScience. 2022;25:103790 pubmed publisher
  15. Lopes N, Boucherit N, Santamaria J, Provin N, Charaix J, Ferrier P, et al. Thymocytes trigger self-antigen-controlling pathways in immature medullary thymic epithelial stages. elife. 2022;11: pubmed publisher
  16. Quách T, Huang W, Sahu R, Diadhiou C, Raparia C, Johnson R, et al. Context-dependent induction of autoimmunity by TNF signaling deficiency. JCI Insight. 2022;7: pubmed publisher
  17. Keller E, Dvorina N, Jørgensen T. Spontaneous CD4+ T Cell Activation and Differentiation in Lupus-Prone B6.Nba2 Mice Is IFNAR-Independent. Int J Mol Sci. 2022;23: pubmed publisher
  18. Yang K, Han J, Asada M, Gill J, Park J, Sathe M, et al. Cytoplasmic RNA quality control failure engages mTORC1-mediated autoinflammatory disease. J Clin Invest. 2022;132: pubmed publisher
  19. Ngamsri K, Putri R, Jans C, Schindler K, Fuhr A, Zhang Y, et al. CXCR4 and CXCR7 Inhibition Ameliorates the Formation of Platelet-Neutrophil Complexes and Neutrophil Extracellular Traps through Adora2b Signaling. Int J Mol Sci. 2021;22: pubmed publisher
  20. Stoff M, Ebbecke T, Ciurkiewicz M, Pavasutthipaisit S, Mayer Lambertz S, St xf6 rk T, et al. C-type lectin receptor DCIR contributes to hippocampal injury in acute neurotropic virus infection. Sci Rep. 2021;11:23819 pubmed publisher
  21. Fahy N, Palomares Cabeza V, Lolli A, Witte Bouma J, Merino A, Ridwan Y, et al. Chondrogenically Primed Human Mesenchymal Stem Cells Persist and Undergo Early Stages of Endochondral Ossification in an Immunocompetent Xenogeneic Model. Front Immunol. 2021;12:715267 pubmed publisher
  22. Susukida T, Kuwahara S, Song B, Kazaoka A, Aoki S, Ito K. Regulation of the immune tolerance system determines the susceptibility to HLA-mediated abacavir-induced skin toxicity. Commun Biol. 2021;4:1137 pubmed publisher
  23. Yang M, Long D, Hu L, Zhao Z, Li Q, Guo Y, et al. AIM2 deficiency in B cells ameliorates systemic lupus erythematosus by regulating Blimp-1-Bcl-6 axis-mediated B-cell differentiation. Signal Transduct Target Ther. 2021;6:341 pubmed publisher
  24. Wright J, Bazile C, Clark E, Carlesso G, Boucher J, Kleiman E, et al. Impaired B Cell Apoptosis Results in Autoimmunity That Is Alleviated by Ablation of Btk. Front Immunol. 2021;12:705307 pubmed publisher
  25. Wang Z, He L, Li W, Xu C, Zhang J, Wang D, et al. GDF15 induces immunosuppression via CD48 on regulatory T cells in hepatocellular carcinoma. J Immunother Cancer. 2021;9: pubmed publisher
  26. Malenica I, Adam J, Corgnac S, Mezquita L, Auclin E, Damei I, et al. Integrin-αV-mediated activation of TGF-β regulates anti-tumour CD8 T cell immunity and response to PD-1 blockade. Nat Commun. 2021;12:5209 pubmed publisher
  27. Moreira T, Mangani D, Cox L, Leibowitz J, Lobo E, Oliveira M, et al. PD-L1+ and XCR1+ dendritic cells are region-specific regulators of gut homeostasis. Nat Commun. 2021;12:4907 pubmed publisher
  28. Winn N, Wolf E, Cottam M, Bhanot M, Hasty A. Myeloid-specific deletion of ferroportin impairs macrophage bioenergetics but is disconnected from systemic insulin action in adult mice. Am J Physiol Endocrinol Metab. 2021;321:E376-E391 pubmed publisher
  29. Kim G, Kim W, Lim S, Lee H, Koo J, Nam K, et al. In Vivo Induction of Regulatory T Cells Via CTLA-4 Signaling Peptide to Control Autoimmune Encephalomyelitis and Prevent Disease Relapse. Adv Sci (Weinh). 2021;8:2004973 pubmed publisher
  30. Van De Velde L, Allen E, Crawford J, Wilson T, Guy C, Russier M, et al. Neuroblastoma Formation Requires Unconventional CD4 T Cells and Arginase-1-Dependent Myeloid Cells. Cancer Res. 2021;81:5047-5059 pubmed publisher
  31. Ortega Molina A, Lebrero Fernández C, Sanz A, Deleyto Seldas N, Plata Gómez A, Menéndez C, et al. Inhibition of Rag GTPase signaling in mice suppresses B cell responses and lymphomagenesis with minimal detrimental trade-offs. Cell Rep. 2021;36:109372 pubmed publisher
  32. Bohannon C, Ende Z, Cao W, Mboko W, Ranjan P, Kumar A, et al. Influenza Virus Infects and Depletes Activated Adaptive Immune Responders. Adv Sci (Weinh). 2021;8:e2100693 pubmed publisher
  33. Ryu S, Shchukina I, Youm Y, Qing H, Hilliard B, Dlugos T, et al. Ketogenic diet restrains aging-induced exacerbation of coronavirus infection in mice. elife. 2021;10: pubmed publisher
  34. Lacy M, Burger C, Shami A, Ahmadsei M, Winkels H, Nitz K, et al. Cell-specific and divergent roles of the CD40L-CD40 axis in atherosclerotic vascular disease. Nat Commun. 2021;12:3754 pubmed publisher
  35. Ho D, Tsui Y, Chan L, Sze K, Zhang X, Cheu J, et al. Single-cell RNA sequencing shows the immunosuppressive landscape and tumor heterogeneity of HBV-associated hepatocellular carcinoma. Nat Commun. 2021;12:3684 pubmed publisher
  36. Okunuki Y, Tabor S, Lee M, Connor K. CD47 Deficiency Ameliorates Ocular Autoimmune Inflammation. Front Immunol. 2021;12:680568 pubmed publisher
  37. Barker K, Etesami N, Shenoy A, Arafa E, Lyon de Ana C, Smith N, et al. Lung-resident memory B cells protect against bacterial pneumonia. J Clin Invest. 2021;131: pubmed publisher
  38. Clemen R, Freund E, Mrochen D, Miebach L, Schmidt A, Rauch B, et al. Gas Plasma Technology Augments Ovalbumin Immunogenicity and OT-II T Cell Activation Conferring Tumor Protection in Mice. Adv Sci (Weinh). 2021;8:2003395 pubmed publisher
  39. Glassman C, Su L, Majri Morrison S, Winkelmann H, Mo F, Li P, et al. Calibration of cell-intrinsic interleukin-2 response thresholds guides design of a regulatory T cell biased agonist. elife. 2021;10: pubmed publisher
  40. Borkner L, Curham L, Wilk M, Moran B, Mills K. IL-17 mediates protective immunity against nasal infection with Bordetella pertussis by mobilizing neutrophils, especially Siglec-F+ neutrophils. Mucosal Immunol. 2021;14:1183-1202 pubmed publisher
  41. Amoozgar Z, Kloepper J, Ren J, Tay R, Kazer S, Kiner E, et al. Targeting Treg cells with GITR activation alleviates resistance to immunotherapy in murine glioblastomas. Nat Commun. 2021;12:2582 pubmed publisher
  42. Kalinina A, Khromykh L, Kazansky D, Deykin A, Silaeva Y. Suppression of the Immune Response by Syngeneic Splenocytes Adoptively Transferred to Sublethally Irradiated Mice. Acta Naturae. 2021;13:116-126 pubmed publisher
  43. Zhang S, Li L, Xie D, Reddy S, Sleasman J, Ma L, et al. Regulation of Intrinsic and Bystander T Follicular Helper Cell Differentiation and Autoimmunity by Tsc1. Front Immunol. 2021;12:620437 pubmed publisher
  44. Can xe8 S, Van Snick J, Uyttenhove C, Pilotte L, van den Eynde B. TGFβ1 neutralization displays therapeutic efficacy through both an immunomodulatory and a non-immune tumor-intrinsic mechanism. J Immunother Cancer. 2021;9: pubmed publisher
  45. Hamminger P, Marchetti L, Preglej T, Platzer R, Zhu C, Kamnev A, et al. Histone deacetylase 1 controls CD4+ T cell trafficking in autoinflammatory diseases. J Autoimmun. 2021;119:102610 pubmed publisher
  46. Sun Z, Yao Y, You M, Liu J, Guo W, Qi Z, et al. The kinase PDK1 is critical for promoting T follicular helper cell differentiation. elife. 2021;10: pubmed publisher
  47. Yao C, Lou G, Sun H, Zhu Z, Sun Y, Chen Z, et al. BACH2 enforces the transcriptional and epigenetic programs of stem-like CD8+ T cells. Nat Immunol. 2021;22:370-380 pubmed publisher
  48. Merkenschlager J, Finkin S, Ramos V, Kraft J, Cipolla M, Nowosad C, et al. Dynamic regulation of TFH selection during the germinal centre reaction. Nature. 2021;591:458-463 pubmed publisher
  49. Ziegler D, Vindrieux D, Goehrig D, Jaber S, Collin G, Griveau A, et al. Calcium channel ITPR2 and mitochondria-ER contacts promote cellular senescence and aging. Nat Commun. 2021;12:720 pubmed publisher
  50. Vavassori V, Mercuri E, Marcovecchio G, Castiello M, Schiroli G, Albano L, et al. Modeling, optimization, and comparable efficacy of T cell and hematopoietic stem cell gene editing for treating hyper-IgM syndrome. EMBO Mol Med. 2021;13:e13545 pubmed publisher
  51. Angulo G, Železnjak J, Martínez Vicente P, Puñet Ortiz J, Hengel H, Messerle M, et al. Cytomegalovirus restricts ICOSL expression on antigen-presenting cells disabling T cell co-stimulation and contributing to immune evasion. elife. 2021;10: pubmed publisher
  52. Suah A, Tran D, Khiew S, Andrade M, Pollard J, Jain D, et al. Pregnancy-induced humoral sensitization overrides T cell tolerance to fetus-matched allografts in mice. J Clin Invest. 2021;131: pubmed publisher
  53. Webb L, Fra Bido S, Innocentin S, Matheson L, Attaf N, Bignon A, et al. Ageing promotes early T follicular helper cell differentiation by modulating expression of RBPJ. Aging Cell. 2021;20:e13295 pubmed publisher
  54. Grand M, Waqasi M, Demarta Gatsi C, Wei Y, Peronet R, Commere P, et al. Hepatic Inflammation Confers Protective Immunity Against Liver Stages of Malaria Parasite. Front Immunol. 2020;11:585502 pubmed publisher
  55. Meryk A, Grasse M, Balasco L, Kapferer W, Grubeck Loebenstein B, Pangrazzi L. Antioxidants N-Acetylcysteine and Vitamin C Improve T Cell Commitment to Memory and Long-Term Maintenance of Immunological Memory in Old Mice. Antioxidants (Basel). 2020;9: pubmed publisher
  56. Rundqvist H, Veliça P, Barbieri L, Gameiro P, Bargiela D, Gojkovic M, et al. Cytotoxic T-cells mediate exercise-induced reductions in tumor growth. elife. 2020;9: pubmed publisher
  57. Ishii K, Pouzolles M, Chien C, Erwin Cohen R, Kohler M, Qin H, et al. Perforin-deficient CAR T cells recapitulate late-onset inflammatory toxicities observed in patients. J Clin Invest. 2020;130:5425-5443 pubmed publisher
  58. Zhao L, Hu S, Davila M, Yang J, Lin Y, Albanese J, et al. Coordinated co-migration of CCR10+ antibody-producing B cells with helper T cells for colonic homeostatic regulation. Mucosal Immunol. 2021;14:420-430 pubmed publisher
  59. Fernandes R, Li C, Wang G, Yang X, Savvides C, Glassman C, et al. Discovery of surrogate agonists for visceral fat Treg cells that modulate metabolic indices in vivo. elife. 2020;9: pubmed publisher
  60. Malacco N, Souza J, Martins F, Rachid M, Simplicio J, Tirapelli C, et al. Chronic ethanol consumption compromises neutrophil function in acute pulmonary Aspergillus fumigatus infection. elife. 2020;9: pubmed publisher
  61. Peligero Cruz C, Givony T, Sebé Pedrós A, Dobes J, Kadouri N, Nevo S, et al. IL18 signaling promotes homing of mature Tregs into the thymus. elife. 2020;9: pubmed publisher
  62. Svensson M, Zoccheddu M, Yang S, Nygaard G, Secchi C, Doody K, et al. Synoviocyte-targeted therapy synergizes with TNF inhibition in arthritis reversal. Sci Adv. 2020;6:eaba4353 pubmed publisher
  63. Danzer H, Glaesner J, Baerenwaldt A, Reitinger C, Lux A, Heger L, et al. Human Fcγ-receptor IIb modulates pathogen-specific versus self-reactive antibody responses in lyme arthritis. elife. 2020;9: pubmed publisher
  64. Bekeschus S, Clemen R, Nießner F, Sagwal S, Freund E, Schmidt A. Medical Gas Plasma Jet Technology Targets Murine Melanoma in an Immunogenic Fashion. Adv Sci (Weinh). 2020;7:1903438 pubmed publisher
  65. Castiello M, Bosticardo M, Sacchetti N, Calzoni E, Fontana E, Yamazaki Y, et al. Efficacy and safety of anti-CD45-saporin as conditioning agent for RAG deficiency. J Allergy Clin Immunol. 2021;147:309-320.e6 pubmed publisher
  66. Zheng D, Gao F, Cheng Q, Bao P, Dong X, Fan J, et al. A vaccine-based nanosystem for initiating innate immunity and improving tumor immunotherapy. Nat Commun. 2020;11:1985 pubmed publisher
  67. Zhu M, Ma Y, Tan K, Zhang L, Wang Z, Li Y, et al. Thalidomide with blockade of co-stimulatory molecules prolongs the survival of alloantigen-primed mice with cardiac allografts. BMC Immunol. 2020;21:19 pubmed publisher
  68. Luoni M, Giannelli S, Indrigo M, Niro A, Massimino L, Iannielli A, et al. Whole brain delivery of an instability-prone Mecp2 transgene improves behavioral and molecular pathological defects in mouse models of Rett syndrome. elife. 2020;9: pubmed publisher
  69. von Roemeling C, Wang Y, Qie Y, Yuan H, Zhao H, Liu X, et al. Therapeutic modulation of phagocytosis in glioblastoma can activate both innate and adaptive antitumour immunity. Nat Commun. 2020;11:1508 pubmed publisher
  70. Gao M, Wang T, Ji L, Bai S, Tian L, Song H. Therapy With Carboplatin and Anti-PD-1 Antibodies Before Surgery Demonstrates Sustainable Anti-Tumor Effects for Secondary Cancers in Mice With Triple-Negative Breast Cancer. Front Immunol. 2020;11:366 pubmed publisher
  71. Zhang S, Liang W, Luo L, Sun S, Wang F. The role of T cell trafficking in CTLA-4 blockade-induced gut immunopathology. BMC Biol. 2020;18:29 pubmed publisher
  72. Ramstead A, Wallace J, Lee S, Bauer K, Tang W, Ekiz H, et al. Mitochondrial Pyruvate Carrier 1 Promotes Peripheral T Cell Homeostasis through Metabolic Regulation of Thymic Development. Cell Rep. 2020;30:2889-2899.e6 pubmed publisher
  73. Kumar A, Chamoto K, Chowdhury P, Honjo T. Tumors attenuating the mitochondrial activity in T cells escape from PD-1 blockade therapy. elife. 2020;9: pubmed publisher
  74. Hajaj E, Eisenberg G, Klein S, Frankenburg S, Merims S, Ben David I, et al. SLAMF6​ deficiency augments tumor killing and skews toward an effector phenotype revealing it as a novel T cell checkpoint. elife. 2020;9: pubmed publisher
  75. Martens R, Permanyer M, Werth K, Yu K, Braun A, Halle O, et al. Efficient homing of T cells via afferent lymphatics requires mechanical arrest and integrin-supported chemokine guidance. Nat Commun. 2020;11:1114 pubmed publisher
  76. Chen H, Cong X, Wu C, Wu X, Wang J, Mao K, et al. Intratumoral delivery of CCL25 enhances immunotherapy against triple-negative breast cancer by recruiting CCR9+ T cells. Sci Adv. 2020;6:eaax4690 pubmed publisher
  77. Angenendt A, Steiner R, Knörck A, Schwär G, Konrad M, Krause E, et al. Orai, STIM, and PMCA contribute to reduced calcium signal generation in CD8+ T cells of elderly mice. Aging (Albany NY). 2020;12:3266-3286 pubmed publisher
  78. Lee J, Zhang J, Chung Y, Kim J, Kook C, Gonzalez Navajas J, et al. Inhibition of IRF4 in dendritic cells by PRR-independent and -dependent signals inhibit Th2 and promote Th17 responses. elife. 2020;9: pubmed publisher
  79. Parisi G, Saco J, Salazar F, Tsoi J, Krystofinski P, Puig Saus C, et al. Persistence of adoptively transferred T cells with a kinetically engineered IL-2 receptor agonist. Nat Commun. 2020;11:660 pubmed publisher
  80. Canel M, Taggart D, Sims A, Lonergan D, Waizenegger I, Serrels A. T-cell co-stimulation in combination with targeting FAK drives enhanced anti-tumor immunity. elife. 2020;9: pubmed publisher
  81. Williford J, Ishihara J, Ishihara A, Mansurov A, Hosseinchi P, Marchell T, et al. Recruitment of CD103+ dendritic cells via tumor-targeted chemokine delivery enhances efficacy of checkpoint inhibitor immunotherapy. Sci Adv. 2019;5:eaay1357 pubmed publisher
  82. Guo C, Allen B, Hiam K, Dodd D, Van Treuren W, Higginbottom S, et al. Depletion of microbiome-derived molecules in the host using Clostridium genetics. Science. 2019;366: pubmed publisher
  83. Zhao Y, Yang Q, Jin C, Feng Y, Xie S, Xie H, et al. Changes of CD103-expressing pulmonary CD4+ and CD8+ T cells in S. japonicum infected C57BL/6 mice. BMC Infect Dis. 2019;19:999 pubmed publisher
  84. Wang L, Shen E, Luo L, Rabe H, Wang Q, Yin J, et al. Control of Germinal Center Localization and Lineage Stability of Follicular Regulatory T Cells by the Blimp1 Transcription Factor. Cell Rep. 2019;29:1848-1861.e6 pubmed publisher
  85. Leone R, Zhao L, Englert J, Sun I, Oh M, Sun I, et al. Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion. Science. 2019;366:1013-1021 pubmed publisher
  86. Strickley J, Messerschmidt J, Awad M, Li T, Hasegawa T, Ha D, et al. Immunity to commensal papillomaviruses protects against skin cancer. Nature. 2019;: pubmed publisher
  87. Lin F, Meng X, Guo Y, Cao W, Liu W, Xia Q, et al. Epigenetic initiation of the TH17 differentiation program is promoted by Cxxc finger protein 1. Sci Adv. 2019;5:eaax1608 pubmed publisher
  88. Yadava K, Medina C, Ishak H, Gurevich I, Kuipers H, Shamskhou E, et al. Natural Tr1-like cells do not confer long-term tolerogenic memory. elife. 2019;8: pubmed publisher
  89. Mani V, Bromley S, Aijö T, Mora Buch R, Carrizosa E, Warner R, et al. Migratory DCs activate TGF-β to precondition naïve CD8+ T cells for tissue-resident memory fate. Science. 2019;366: pubmed publisher
  90. Shikama Y, Kurosawa M, Furukawa M, Ishimaru N, Matsushita K. Involvement of adiponectin in age-related increases in tear production in mice. Aging (Albany NY). 2019;11:8329-8346 pubmed publisher
  91. Benechet A, De Simone G, Di Lucia P, Cilenti F, Barbiera G, Le Bert N, et al. Dynamics and genomic landscape of CD8+ T cells undergoing hepatic priming. Nature. 2019;574:200-205 pubmed publisher
  92. Majer O, Liu B, Kreuk L, Krogan N, Barton G. UNC93B1 recruits syntenin-1 to dampen TLR7 signalling and prevent autoimmunity. Nature. 2019;575:366-370 pubmed publisher
  93. Sanz Ortega L, Rojas J, Portilla Y, Pérez Yagüe S, Barber D. Magnetic Nanoparticles Attached to the NK Cell Surface for Tumor Targeting in Adoptive Transfer Therapies Does Not Affect Cellular Effector Functions. Front Immunol. 2019;10:2073 pubmed publisher
  94. Rasoulouniriana D, Santana Magal N, Gutwillig A, Farhat Younis L, Wine Y, Saperia C, et al. A distinct subset of FcγRI-expressing Th1 cells exert antibody-mediated cytotoxic activity. J Clin Invest. 2019;129:4151-4164 pubmed publisher
  95. Jordan S, Tung N, Casanova Acebes M, Chang C, Cantoni C, Zhang D, et al. Dietary Intake Regulates the Circulating Inflammatory Monocyte Pool. Cell. 2019;178:1102-1114.e17 pubmed publisher
  96. Collins N, Han S, Enamorado M, Link V, Huang B, Moseman E, et al. The Bone Marrow Protects and Optimizes Immunological Memory during Dietary Restriction. Cell. 2019;178:1088-1101.e15 pubmed publisher
  97. Verma V, Shrimali R, Ahmad S, Dai W, Wang H, Lu S, et al. PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1+CD38hi cells and anti-PD-1 resistance. Nat Immunol. 2019;20:1231-1243 pubmed publisher
  98. Wirsching H, Zhang H, Szulzewsky F, Arora S, Grandi P, Cimino P, et al. Arming oHSV with ULBP3 drives abscopal immunity in lymphocyte-depleted glioblastoma. JCI Insight. 2019;4: pubmed publisher
  99. Papaioannou E, Yanez D, Ross S, Lau C, Solanki A, Chawda M, et al. Sonic Hedgehog signaling limits atopic dermatitis via Gli2-driven immune regulation. J Clin Invest. 2019;129:3153-3170 pubmed publisher
  100. Khanom U, Ohigashi I, Fujimori S, Kondo K, Takada K, Takahama Y. TCR Affinity for In Vivo Peptide-Induced Thymic Positive Selection Fine-Tunes TCR Responsiveness of Peripheral CD8+ T Cells. J Immunol. 2019;: pubmed publisher
  101. Koike T, Harada K, Horiuchi S, Kitamura D. The quantity of CD40 signaling determines the differentiation of B cells into functionally distinct memory cell subsets. elife. 2019;8: pubmed publisher
  102. Khan O, Giles J, McDonald S, Manne S, Ngiow S, Patel K, et al. TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion. Nature. 2019;: pubmed publisher
  103. Celis Gutierrez J, Blattmann P, Zhai Y, Jarmuzynski N, Ruminski K, Gregoire C, et al. Quantitative Interactomics in Primary T Cells Provides a Rationale for Concomitant PD-1 and BTLA Coinhibitor Blockade in Cancer Immunotherapy. Cell Rep. 2019;27:3315-3330.e7 pubmed publisher
  104. von Gamm M, Schaub A, Jones A, Wolf C, Behrens G, Lichti J, et al. Immune homeostasis and regulation of the interferon pathway require myeloid-derived Regnase-3. J Exp Med. 2019;: pubmed publisher
  105. Di Pilato M, Kim E, Cadilha B, Prüßmann J, Nasrallah M, Seruggia D, et al. Targeting the CBM complex causes Treg cells to prime tumours for immune checkpoint therapy. Nature. 2019;570:112-116 pubmed publisher
  106. Qiu J, Villa M, Sanin D, Buck M, O Sullivan D, Ching R, et al. Acetate Promotes T Cell Effector Function during Glucose Restriction. Cell Rep. 2019;27:2063-2074.e5 pubmed publisher
  107. LaFleur M, Nguyen T, Coxe M, Yates K, Trombley J, Weiss S, et al. A CRISPR-Cas9 delivery system for in vivo screening of genes in the immune system. Nat Commun. 2019;10:1668 pubmed publisher
  108. Misumi I, Starmer J, Uchimura T, Beck M, Magnuson T, Whitmire J. Obesity Expands a Distinct Population of T Cells in Adipose Tissue and Increases Vulnerability to Infection. Cell Rep. 2019;27:514-524.e5 pubmed publisher
  109. Visekruna A, Hartmann S, Sillke Y, Glauben R, Fischer F, Raifer H, et al. Intestinal development and homeostasis require activation and apoptosis of diet-reactive T cells. J Clin Invest. 2019;129:1972-1983 pubmed publisher
  110. Cao Y, Trillo Tinoco J, Sierra R, Anadon C, Dai W, Mohamed E, et al. ER stress-induced mediator C/EBP homologous protein thwarts effector T cell activity in tumors through T-bet repression. Nat Commun. 2019;10:1280 pubmed publisher
  111. Lee J, Stone M, Porrett P, Thomas S, Komar C, Li J, et al. Hepatocytes direct the formation of a pro-metastatic niche in the liver. Nature. 2019;567:249-252 pubmed publisher
  112. Xing S, Gai K, Li X, Shao P, Zeng Z, Zhao X, et al. Tcf1 and Lef1 are required for the immunosuppressive function of regulatory T cells. J Exp Med. 2019;: pubmed publisher
  113. Lodygin D, Hermann M, Schweingruber N, Flügel Koch C, Watanabe T, Schlosser C, et al. β-Synuclein-reactive T cells induce autoimmune CNS grey matter degeneration. Nature. 2019;566:503-508 pubmed publisher
  114. Geng S, Zhang Y, Lee C, Li L. Novel reprogramming of neutrophils modulates inflammation resolution during atherosclerosis. Sci Adv. 2019;5:eaav2309 pubmed publisher
  115. Yamamoto T, Lee P, Vodnala S, Gurusamy D, Kishton R, Yu Z, et al. T cells genetically engineered to overcome death signaling enhance adoptive cancer immunotherapy. J Clin Invest. 2019;129:1551-1565 pubmed publisher
  116. Faliti C, Gualtierotti R, Rottoli E, Gerosa M, Perruzza L, Romagnani A, et al. P2X7 receptor restrains pathogenic Tfh cell generation in systemic lupus erythematosus. J Exp Med. 2019;216:317-336 pubmed publisher
  117. McLaren J, Clement M, Marsden M, Miners K, Llewellyn Lacey S, Grant E, et al. IL-33 Augments Virus-Specific Memory T Cell Inflation and Potentiates the Efficacy of an Attenuated Cytomegalovirus-Based Vaccine. J Immunol. 2019;202:943-955 pubmed publisher
  118. Li J, He Y, Hao J, Ni L, Dong C. High Levels of Eomes Promote Exhaustion of Anti-tumor CD8+ T Cells. Front Immunol. 2018;9:2981 pubmed publisher
  119. Li F, Zeng Z, Xing S, Gullicksrud J, Shan Q, Choi J, et al. Ezh2 programs TFH differentiation by integrating phosphorylation-dependent activation of Bcl6 and polycomb-dependent repression of p19Arf. Nat Commun. 2018;9:5452 pubmed publisher
  120. Karmaus P, Chen X, Lim S, Herrada A, Nguyen T, Xu B, et al. Metabolic heterogeneity underlies reciprocal fates of TH17 cell stemness and plasticity. Nature. 2019;565:101-105 pubmed publisher
  121. Chorro L, Suzuki M, Chin S, Williams T, Snapp E, Odagiu L, et al. Interleukin 2 modulates thymic-derived regulatory T cell epigenetic landscape. Nat Commun. 2018;9:5368 pubmed publisher
  122. Simula L, Pacella I, Colamatteo A, Procaccini C, Cancila V, Bordi M, et al. Drp1 Controls Effective T Cell Immune-Surveillance by Regulating T Cell Migration, Proliferation, and cMyc-Dependent Metabolic Reprogramming. Cell Rep. 2018;25:3059-3073.e10 pubmed publisher
  123. Ding L, Kim H, Wang Q, Kearns M, Jiang T, Ohlson C, et al. PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian Cancer. Cell Rep. 2018;25:2972-2980.e5 pubmed publisher
  124. Poncette L, Chen X, Lorenz F, Blankenstein T. Effective NY-ESO-1-specific MHC II-restricted T cell receptors from antigen-negative hosts enhance tumor regression. J Clin Invest. 2019;129:324-335 pubmed publisher
  125. Sato Y, Bolzenius J, Eteleeb A, Su X, Maher C, Sehn J, et al. CD4+ T cells induce rejection of urothelial tumors after immune checkpoint blockade. JCI Insight. 2018;3: pubmed publisher
  126. Andre P, Denis C, Soulas C, Bourbon Caillet C, Lopez J, Arnoux T, et al. Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells. Cell. 2018;175:1731-1743.e13 pubmed publisher
  127. Atretkhany K, Mufazalov I, Dunst J, Kuchmiy A, Gogoleva V, Andruszewski D, et al. Intrinsic TNFR2 signaling in T regulatory cells provides protection in CNS autoimmunity. Proc Natl Acad Sci U S A. 2018;115:13051-13056 pubmed publisher
  128. Dong S, Harrington B, Hu E, Greene J, Lehman A, Tran M, et al. PI3K p110δ inactivation antagonizes chronic lymphocytic leukemia and reverses T cell immune suppression. J Clin Invest. 2019;129:122-136 pubmed publisher
  129. Ng K, Yui M, Mehta A, Siu S, Irwin B, Pease S, et al. A stochastic epigenetic switch controls the dynamics of T-cell lineage commitment. elife. 2018;7: pubmed publisher
  130. Grohmann M, Wiede F, Dodd G, Gurzov E, Ooi G, Butt T, et al. Obesity Drives STAT-1-Dependent NASH and STAT-3-Dependent HCC. Cell. 2018;175:1289-1306.e20 pubmed publisher
  131. James K, Cosway E, LUCAS B, White A, Parnell S, Carvalho Gaspar M, et al. Endothelial cells act as gatekeepers for LTβR-dependent thymocyte emigration. J Exp Med. 2018;215:2984-2993 pubmed publisher
  132. Klement J, Paschall A, Redd P, Ibrahim M, Lu C, Yang D, et al. An osteopontin/CD44 immune checkpoint controls CD8+ T cell activation and tumor immune evasion. J Clin Invest. 2018;128:5549-5560 pubmed publisher
  133. Singh A, Khare P, Obaid A, Conlon K, Basrur V, Depinho R, et al. SUMOylation of ROR-γt inhibits IL-17 expression and inflammation via HDAC2. Nat Commun. 2018;9:4515 pubmed publisher
  134. Humblet Baron S, Barber J, Roca C, Lenaerts A, Koni P, Liston A. Murine myeloproliferative disorder as a consequence of impaired collaboration between dendritic cells and CD4 T cells. Blood. 2018;: pubmed publisher
  135. Vuckovic S, Minnie S, Smith D, Gartlan K, Watkins T, Markey K, et al. Bone marrow transplantation generates T cell-dependent control of myeloma in mice. J Clin Invest. 2019;129:106-121 pubmed publisher
  136. Qiao G, Bucsek M, Winder N, Chen M, Giridharan T, Olejniczak S, et al. β-Adrenergic signaling blocks murine CD8+ T-cell metabolic reprogramming during activation: a mechanism for immunosuppression by adrenergic stress. Cancer Immunol Immunother. 2019;68:11-22 pubmed publisher
  137. Louveau A, Herz J, Alme M, Salvador A, Dong M, Viar K, et al. CNS lymphatic drainage and neuroinflammation are regulated by meningeal lymphatic vasculature. Nat Neurosci. 2018;21:1380-1391 pubmed publisher
  138. Tilstra J, Avery L, Menk A, Gordon R, Smita S, Kane L, et al. Kidney-infiltrating T cells in murine lupus nephritis are metabolically and functionally exhausted. J Clin Invest. 2018;128:4884-4897 pubmed publisher
  139. Singh M, Ni M, Sullivan J, Hamerman J, Campbell D. B cell adaptor for PI3-kinase (BCAP) modulates CD8+ effector and memory T cell differentiation. J Exp Med. 2018;215:2429-2443 pubmed publisher
  140. Baens M, Stirparo R, Lampi Y, Verbeke D, Vandepoel R, Cools J, et al. Malt1 self-cleavage is critical for regulatory T cell homeostasis and anti-tumor immunity in mice. Eur J Immunol. 2018;48:1728-1738 pubmed publisher
  141. Gisterå A, Klement M, Polyzos K, Mailer R, Duhlin A, Karlsson M, et al. LDL-Reactive T Cells Regulate Plasma Cholesterol Levels and Development of Atherosclerosis in Humanized Hypercholesterolemic Mice. Circulation. 2018;: pubmed publisher
  142. Splitt S, Souza S, Valentine K, Castellanos B, Curd A, Hoyer K, et al. PD-L1, TIM-3, and CTLA-4 Blockade Fails To Promote Resistance to Secondary Infection with Virulent Strains of Toxoplasma gondii. Infect Immun. 2018;86: pubmed publisher
  143. Vendetti F, Karukonda P, Clump D, Teo T, Lalonde R, Nugent K, et al. ATR kinase inhibitor AZD6738 potentiates CD8+ T cell-dependent antitumor activity following radiation. J Clin Invest. 2018;128:3926-3940 pubmed publisher
  144. Du X, Wen J, Wang Y, Karmaus P, Khatamian A, Tan H, et al. Hippo/Mst signalling couples metabolic state and immune function of CD8α+ dendritic cells. Nature. 2018;558:141-145 pubmed publisher
  145. Noguchi N, Nakamura R, Hatano S, Yamada H, Sun X, Ohara N, et al. Interleukin-21 Induces Short-Lived Effector CD8+ T Cells but Does Not Inhibit Their Exhaustion after Mycobacterium bovis BCG Infection in Mice. Infect Immun. 2018;86: pubmed publisher
  146. Ma C, Han M, Heinrich B, Fu Q, Zhang Q, Sandhu M, et al. Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells. Science. 2018;360: pubmed publisher
  147. Daenthanasanmak A, Wu Y, Iamsawat S, Nguyen H, Bastian D, Zhang M, et al. PIM-2 protein kinase negatively regulates T cell responses in transplantation and tumor immunity. J Clin Invest. 2018;128:2787-2801 pubmed publisher
  148. García Nores G, Ly C, Cuzzone D, Kataru R, Hespe G, Torrisi J, et al. CD4+ T cells are activated in regional lymph nodes and migrate to skin to initiate lymphedema. Nat Commun. 2018;9:1970 pubmed publisher
  149. Hu X, Majchrzak K, Liu X, Wyatt M, Spooner C, Moisan J, et al. In Vitro Priming of Adoptively Transferred T Cells with a RORγ Agonist Confers Durable Memory and Stemness In Vivo. Cancer Res. 2018;78:3888-3898 pubmed publisher
  150. Borlido J, Sakuma S, Raices M, Carrette F, Tinoco R, Bradley L, et al. Nuclear pore complex-mediated modulation of TCR signaling is required for naïve CD4+ T cell homeostasis. Nat Immunol. 2018;19:594-605 pubmed publisher
  151. Dipiazza A, Laniewski N, Rattan A, Topham D, Miller J, Sant A. CD4 T Cell Epitope Specificity and Cytokine Potential Are Preserved as Cells Transition from the Lung Vasculature to Lung Tissue following Influenza Virus Infection. J Virol. 2018;92: pubmed publisher
  152. Tanaka S, Pfleger C, Lai J, Roan F, Sun S, Ziegler S. KAP1 Regulates Regulatory T Cell Function and Proliferation in Both Foxp3-Dependent and -Independent Manners. Cell Rep. 2018;23:796-807 pubmed publisher
  153. Beutier H, Hechler B, Godon O, Wang Y, Gillis C, de Chaisemartin L, et al. Platelets expressing IgG receptor FcγRIIA/CD32A determine the severity of experimental anaphylaxis. Sci Immunol. 2018;3: pubmed publisher
  154. Panda S, Facchinetti V, Voynova E, Hanabuchi S, Karnell J, Hanna R, et al. Galectin-9 inhibits TLR7-mediated autoimmunity in murine lupus models. J Clin Invest. 2018;128:1873-1887 pubmed publisher
  155. Gaddis D, Padgett L, Wu R, McSkimming C, Romines V, Taylor A, et al. Apolipoprotein AI prevents regulatory to follicular helper T cell switching during atherosclerosis. Nat Commun. 2018;9:1095 pubmed publisher
  156. Safya H, Mellouk A, Legrand J, Le Gall S, Benbijja M, Kanellopoulos Langevin C, et al. Variations in Cellular Responses of Mouse T Cells to Adenosine-5'-Triphosphate Stimulation Do Not Depend on P2X7 Receptor Expression Levels but on Their Activation and Differentiation Stage. Front Immunol. 2018;9:360 pubmed publisher
  157. Khan A, Carpenter B, Santos e Sousa P, Pospori C, Khorshed R, Griffin J, et al. Redirection to the bone marrow improves T cell persistence and antitumor functions. J Clin Invest. 2018;128:2010-2024 pubmed publisher
  158. Omilusik K, Nadjsombati M, Shaw L, Yu B, Milner J, Goldrath A. Sustained Id2 regulation of E proteins is required for terminal differentiation of effector CD8+ T cells. J Exp Med. 2018;215:773-783 pubmed publisher
  159. Zemmour D, Zilionis R, Kiner E, Klein A, Mathis D, Benoist C. Single-cell gene expression reveals a landscape of regulatory T cell phenotypes shaped by the TCR. Nat Immunol. 2018;19:291-301 pubmed publisher
  160. Doorduijn E, Sluijter M, Marijt K, Querido B, van der Burg S, van Hall T. T cells specific for a TAP-independent self-peptide remain naïve in tumor-bearing mice and are fully exploitable for therapy. Oncoimmunology. 2018;7:e1382793 pubmed publisher
  161. Ehlers L, Rohde S, Ibrahim S, Jaster R. Adoptive transfer of CD3+ T cells and CD4+ CD44high memory T cells induces autoimmune pancreatitis in MRL/MpJ mice. J Cell Mol Med. 2018;22:2404-2412 pubmed publisher
  162. Koh A, Miller E, Buenrostro J, Moskowitz D, Wang J, Greenleaf W, et al. Rapid chromatin repression by Aire provides precise control of immune tolerance. Nat Immunol. 2018;19:162-172 pubmed publisher
  163. Ferdinand J, Richard A, Meylan F, Al Shamkhani A, Siegel R. Cleavage of TL1A Differentially Regulates Its Effects on Innate and Adaptive Immune Cells. J Immunol. 2018;200:1360-1369 pubmed publisher
  164. Kaufmann E, Sanz J, Dunn J, Khan N, Mendonça L, Pacis A, et al. BCG Educates Hematopoietic Stem Cells to Generate Protective Innate Immunity against Tuberculosis. Cell. 2018;172:176-190.e19 pubmed publisher
  165. Ibitokou S, Dillon B, Sinha M, Szczesny B, Delgadillo A, Reda Abdelrahman D, et al. Early Inhibition of Fatty Acid Synthesis Reduces Generation of Memory Precursor Effector T Cells in Chronic Infection. J Immunol. 2018;200:643-656 pubmed publisher
  166. Kishore M, Cheung K, Fu H, Bonacina F, Wang G, Coe D, et al. Regulatory T Cell Migration Is Dependent on Glucokinase-Mediated Glycolysis. Immunity. 2017;47:875-889.e10 pubmed publisher
  167. Ernszt D, Banfai K, Kellermayer Z, Pap A, Lord J, Pongracz J, et al. PPARgamma Deficiency Counteracts Thymic Senescence. Front Immunol. 2017;8:1515 pubmed publisher
  168. Singh M, Vianden C, Cantwell M, Dai Z, Xiao Z, Sharma M, et al. Intratumoral CD40 activation and checkpoint blockade induces T cell-mediated eradication of melanoma in the brain. Nat Commun. 2017;8:1447 pubmed publisher
  169. Capece T, Walling B, Lim K, Kim K, Bae S, Chung H, et al. A novel intracellular pool of LFA-1 is critical for asymmetric CD8+ T cell activation and differentiation. J Cell Biol. 2017;216:3817-3829 pubmed publisher
  170. Danahy D, Anthony S, Jensen I, Hartwig S, Shan Q, Xue H, et al. Polymicrobial sepsis impairs bystander recruitment of effector cells to infected skin despite optimal sensing and alarming function of skin resident memory CD8 T cells. PLoS Pathog. 2017;13:e1006569 pubmed publisher
  171. Billerbeck E, Wolfisberg R, Fahnøe U, Xiao J, Quirk C, Luna J, et al. Mouse models of acute and chronic hepacivirus infection. Science. 2017;357:204-208 pubmed publisher
  172. Sitrin J, Suto E, Wuster A, Eastham Anderson J, Kim J, Austin C, et al. The Ox40/Ox40 Ligand Pathway Promotes Pathogenic Th Cell Responses, Plasmablast Accumulation, and Lupus Nephritis in NZB/W F1 Mice. J Immunol. 2017;199:1238-1249 pubmed publisher
  173. Lingel H, Wissing J, Arra A, Schanze D, Lienenklaus S, Klawonn F, et al. CTLA-4-mediated posttranslational modifications direct cytotoxic T-lymphocyte differentiation. Cell Death Differ. 2017;24:1739-1749 pubmed publisher
  174. Levine A, Mendoza A, Hemmers S, Moltedo B, Niec R, Schizas M, et al. Stability and function of regulatory T cells expressing the transcription factor T-bet. Nature. 2017;546:421-425 pubmed publisher
  175. Hasan Z, Koizumi S, Sasaki D, Yamada H, Arakaki N, Fujihara Y, et al. JunB is essential for IL-23-dependent pathogenicity of Th17 cells. Nat Commun. 2017;8:15628 pubmed publisher
  176. Mendoza A, Fang V, Chen C, Serasinghe M, Verma A, Muller J, et al. Lymphatic endothelial S1P promotes mitochondrial function and survival in naive T cells. Nature. 2017;546:158-161 pubmed publisher
  177. Mildner A, Schönheit J, Giladi A, David E, Lara Astiaso D, Lorenzo Vivas E, et al. Genomic Characterization of Murine Monocytes Reveals C/EBP? Transcription Factor Dependence of Ly6C- Cells. Immunity. 2017;46:849-862.e7 pubmed publisher
  178. Lis R, Karrasch C, Poulos M, Kunar B, Redmond D, Duran J, et al. Conversion of adult endothelium to immunocompetent haematopoietic stem cells. Nature. 2017;545:439-445 pubmed publisher
  179. Miao T, Symonds A, Singh R, Symonds J, Ogbe A, Omodho B, et al. Egr2 and 3 control adaptive immune responses by temporally uncoupling expansion from T cell differentiation. J Exp Med. 2017;214:1787-1808 pubmed publisher
  180. Chowdhary V, Krogman A, Tilahun A, Alexander M, David C, Rajagopalan G. Concomitant Disruption of CD4 and CD8 Genes Facilitates the Development of Double Negative ?? TCR+ Peripheral T Cells That Respond Robustly to Staphylococcal Superantigen. J Immunol. 2017;198:4413-4424 pubmed publisher
  181. Daley D, Mani V, Mohan N, Akkad N, Pandian G, Savadkar S, et al. NLRP3 signaling drives macrophage-induced adaptive immune suppression in pancreatic carcinoma. J Exp Med. 2017;214:1711-1724 pubmed publisher
  182. Acharya N, Penukonda S, Shcheglova T, Hagymasi A, Basu S, Srivastava P. Endocannabinoid system acts as a regulator of immune homeostasis in the gut. Proc Natl Acad Sci U S A. 2017;114:5005-5010 pubmed publisher
  183. Gittens B, Bodkin J, Nourshargh S, Perretti M, Cooper D. Galectin-3: A Positive Regulator of Leukocyte Recruitment in the Inflamed Microcirculation. J Immunol. 2017;198:4458-4469 pubmed publisher
  184. Fu G, Xu Q, Qiu Y, Jin X, Xu T, Dong S, et al. Suppression of Th17 cell differentiation by misshapen/NIK-related kinase MINK1. J Exp Med. 2017;214:1453-1469 pubmed publisher
  185. Claser C, de Souza J, Thorburn S, Grau G, Riley E, Renia L, et al. Host Resistance to Plasmodium-Induced Acute Immune Pathology Is Regulated by Interleukin-10 Receptor Signaling. Infect Immun. 2017;85: pubmed publisher
  186. Daley D, Mani V, Mohan N, Akkad N, Ochi A, Heindel D, et al. Dectin 1 activation on macrophages by galectin 9 promotes pancreatic carcinoma and peritumoral immune tolerance. Nat Med. 2017;23:556-567 pubmed publisher
  187. Lehmann C, Baranska A, Heidkamp G, Heger L, Neubert K, Lühr J, et al. DC subset-specific induction of T cell responses upon antigen uptake via Fc? receptors in vivo. J Exp Med. 2017;214:1509-1528 pubmed publisher
  188. Bouziat R, Hinterleitner R, Brown J, Stencel Baerenwald J, Ikizler M, Mayassi T, et al. Reovirus infection triggers inflammatory responses to dietary antigens and development of celiac disease. Science. 2017;356:44-50 pubmed publisher
  189. Martinez Jimenez C, Eling N, Chen H, Vallejos C, Kolodziejczyk A, Connor F, et al. Aging increases cell-to-cell transcriptional variability upon immune stimulation. Science. 2017;355:1433-1436 pubmed publisher
  190. Sindhava V, Oropallo M, Moody K, Naradikian M, Higdon L, Zhou L, et al. A TLR9-dependent checkpoint governs B cell responses to DNA-containing antigens. J Clin Invest. 2017;127:1651-1663 pubmed publisher
  191. González Pérez G, Lamousé Smith E. Gastrointestinal Microbiome Dysbiosis in Infant Mice Alters Peripheral CD8+ T Cell Receptor Signaling. Front Immunol. 2017;8:265 pubmed publisher
  192. Klein J, Moses K, Zelinskyy G, Sody S, Buer J, Lang S, et al. Combined toll-like receptor 3/7/9 deficiency on host cells results in T-cell-dependent control of tumour growth. Nat Commun. 2017;8:14600 pubmed publisher
  193. Bhattacharyya M, Penaloza MacMaster P. T regulatory cells are critical for the maintenance, anamnestic expansion and protection elicited by vaccine-induced CD8 T cells. Immunology. 2017;151:340-348 pubmed publisher
  194. Ansa Addo E, Zhang Y, Yang Y, Hussey G, Howley B, Salem M, et al. Membrane-organizing protein moesin controls Treg differentiation and antitumor immunity via TGF-β signaling. J Clin Invest. 2017;127:1321-1337 pubmed publisher
  195. Pishesha N, Bilate A, Wibowo M, Huang N, Li Z, Deshycka R, et al. Engineered erythrocytes covalently linked to antigenic peptides can protect against autoimmune disease. Proc Natl Acad Sci U S A. 2017;114:3157-3162 pubmed publisher
  196. Ramos G, van den Berg A, Nunes Silva V, Weirather J, Peters L, Burkard M, et al. Myocardial aging as a T-cell-mediated phenomenon. Proc Natl Acad Sci U S A. 2017;114:E2420-E2429 pubmed publisher
  197. Baranek T, Morello E, Valayer A, Aimar R, Bréa D, Henry C, et al. FHL2 Regulates Natural Killer Cell Development and Activation during Streptococcus pneumoniae Infection. Front Immunol. 2017;8:123 pubmed publisher
  198. Rubtsova K, Rubtsov A, Thurman J, Mennona J, Kappler J, Marrack P. B cells expressing the transcription factor T-bet drive lupus-like autoimmunity. J Clin Invest. 2017;127:1392-1404 pubmed publisher
  199. Szabo P, Goswami A, Mazzuca D, Kim K, O Gorman D, Hess D, et al. Rapid and Rigorous IL-17A Production by a Distinct Subpopulation of Effector Memory T Lymphocytes Constitutes a Novel Mechanism of Toxic Shock Syndrome Immunopathology. J Immunol. 2017;198:2805-2818 pubmed publisher
  200. Knudson K, Pritzl C, Saxena V, Altman A, Daniels M, Teixeiro E. NFκB-Pim-1-Eomesodermin axis is critical for maintaining CD8 T-cell memory quality. Proc Natl Acad Sci U S A. 2017;114:E1659-E1667 pubmed publisher
  201. Asano T, Meguri Y, Yoshioka T, Kishi Y, Iwamoto M, Nakamura M, et al. PD-1 modulates regulatory T-cell homeostasis during low-dose interleukin-2 therapy. Blood. 2017;129:2186-2197 pubmed publisher
  202. van Nieuwenhuijze A, Dooley J, Humblet Baron S, Sreenivasan J, Koenders M, Schlenner S, et al. Defective germinal center B-cell response and reduced arthritic pathology in microRNA-29a-deficient mice. Cell Mol Life Sci. 2017;74:2095-2106 pubmed publisher
  203. Chamoto K, Chowdhury P, Kumar A, Sonomura K, Matsuda F, Fagarasan S, et al. Mitochondrial activation chemicals synergize with surface receptor PD-1 blockade for T cell-dependent antitumor activity. Proc Natl Acad Sci U S A. 2017;114:E761-E770 pubmed publisher
  204. Jiang X, Park C, Geddes Sweeney J, Yoo M, Gaide O, Kupper T. Dermal ?? T Cells Do Not Freely Re-Circulate Out of Skin and Produce IL-17 to Promote Neutrophil Infiltration during Primary Contact Hypersensitivity. PLoS ONE. 2017;12:e0169397 pubmed publisher
  205. van der Weyden L, Arends M, Campbell A, Bald T, Wardle Jones H, Griggs N, et al. Genome-wide in vivo screen identifies novel host regulators of metastatic colonization. Nature. 2017;541:233-236 pubmed publisher
  206. Lamprianou S, Gysemans C, Bou Saab J, Pontes H, Mathieu C, Meda P. Glibenclamide Prevents Diabetes in NOD Mice. PLoS ONE. 2016;11:e0168839 pubmed publisher
  207. Hashimoto Hill S, Friesen L, Kim M, Kim C. Contraction of intestinal effector T cells by retinoic acid-induced purinergic receptor P2X7. Mucosal Immunol. 2017;10:912-923 pubmed publisher
  208. Nish S, Zens K, Kratchmarov R, Lin W, Adams W, Chen Y, et al. CD4+ T cell effector commitment coupled to self-renewal by asymmetric cell divisions. J Exp Med. 2017;214:39-47 pubmed publisher
  209. Jacobsen E, Ochkur S, Doyle A, Lesuer W, Li W, Protheroe C, et al. Lung Pathologies in a Chronic Inflammation Mouse Model Are Independent of Eosinophil Degranulation. Am J Respir Crit Care Med. 2017;195:1321-1332 pubmed publisher
  210. Morita K, Okamura T, Inoue M, Komai T, Teruya S, Iwasaki Y, et al. Egr2 and Egr3 in regulatory T cells cooperatively control systemic autoimmunity through Ltbp3-mediated TGF-β3 production. Proc Natl Acad Sci U S A. 2016;113:E8131-E8140 pubmed
  211. Angela M, Endo Y, Asou H, Yamamoto T, Tumes D, Tokuyama H, et al. Fatty acid metabolic reprogramming via mTOR-mediated inductions of PPAR? directs early activation of T cells. Nat Commun. 2016;7:13683 pubmed publisher
  212. Kretzer N, Theisen D, Tussiwand R, Briseño C, Grajales Reyes G, Wu X, et al. RAB43 facilitates cross-presentation of cell-associated antigens by CD8?+ dendritic cells. J Exp Med. 2016;213:2871-2883 pubmed
  213. Cecchinato V, Bernasconi E, Speck R, Proietti M, Sauermann U, D Agostino G, et al. Impairment of CCR6+ and CXCR3+ Th Cell Migration in HIV-1 Infection Is Rescued by Modulating Actin Polymerization. J Immunol. 2017;198:184-195 pubmed
  214. Brinza L, Djebali S, Tomkowiak M, Mafille J, Loiseau C, Jouve P, et al. Immune signatures of protective spleen memory CD8 T cells. Sci Rep. 2016;6:37651 pubmed publisher
  215. Hammer A, Yang G, Friedrich J, Kovacs A, Lee D, Grave K, et al. Role of the receptor Mas in macrophage-mediated inflammation in vivo. Proc Natl Acad Sci U S A. 2016;113:14109-14114 pubmed
  216. Srivastava R, Khan A, Garg S, Syed S, Furness J, Vahed H, et al. Human Asymptomatic Epitopes Identified from the Herpes Simplex Virus Tegument Protein VP13/14 (UL47) Preferentially Recall Polyfunctional Effector Memory CD44high CD62Llow CD8+ TEM Cells and Protect Humanized HLA-A*02:01 Transgenic Mice against Ocula. J Virol. 2017;91: pubmed publisher
  217. Shirakawa K, Yan X, Shinmura K, Endo J, Kataoka M, Katsumata Y, et al. Obesity accelerates T cell senescence in murine visceral adipose tissue. J Clin Invest. 2016;126:4626-4639 pubmed publisher
  218. Laurent C, Dorothee G, Hunot S, Martin E, Monnet Y, Duchamp M, et al. Hippocampal T cell infiltration promotes neuroinflammation and cognitive decline in a mouse model of tauopathy. Brain. 2017;140:184-200 pubmed publisher
  219. Zamora Pineda J, Kumar A, Suh J, Zhang M, Saba J. Dendritic cell sphingosine-1-phosphate lyase regulates thymic egress. J Exp Med. 2016;213:2773-2791 pubmed
  220. Hirako I, Ataide M, Faustino L, Assis P, Sorensen E, Ueta H, et al. Splenic differentiation and emergence of CCR5+CXCL9+CXCL10+ monocyte-derived dendritic cells in the brain during cerebral malaria. Nat Commun. 2016;7:13277 pubmed publisher
  221. Sen D, Kaminski J, Barnitz R, Kurachi M, Gerdemann U, Yates K, et al. The epigenetic landscape of T cell exhaustion. Science. 2016;354:1165-1169 pubmed
  222. Zhao J, Chen C, Guo M, Tao Y, Cui P, Zhou Y, et al. MicroRNA-7 Deficiency Ameliorates the Pathologies of Acute Lung Injury through Elevating KLF4. Front Immunol. 2016;7:389 pubmed
  223. Case A, Roessner C, Tian J, Zimmerman M. Mitochondrial Superoxide Signaling Contributes to Norepinephrine-Mediated T-Lymphocyte Cytokine Profiles. PLoS ONE. 2016;11:e0164609 pubmed publisher
  224. Gerriets V, Kishton R, Johnson M, Cohen S, Siska P, Nichols A, et al. Foxp3 and Toll-like receptor signaling balance Treg cell anabolic metabolism for suppression. Nat Immunol. 2016;17:1459-1466 pubmed publisher
  225. Hrdinka M, Sudan K, Just S, Drobek A, Stepanek O, Schluter D, et al. Normal Development and Function of T Cells in Proline Rich 7 (Prr7) Deficient Mice. PLoS ONE. 2016;11:e0162863 pubmed publisher
  226. Roncagalli R, Cucchetti M, Jarmuzynski N, Gregoire C, Bergot E, Audebert S, et al. The scaffolding function of the RLTPR protein explains its essential role for CD28 co-stimulation in mouse and human T cells. J Exp Med. 2016;213:2437-2457 pubmed
  227. Lexmond W, Goettel J, Lyons J, Jacobse J, Deken M, Lawrence M, et al. FOXP3+ Tregs require WASP to restrain Th2-mediated food allergy. J Clin Invest. 2016;126:4030-4044 pubmed publisher
  228. Di Marco Barros R, Roberts N, Dart R, Vantourout P, Jandke A, Nussbaumer O, et al. Epithelia Use Butyrophilin-like Molecules to Shape Organ-Specific γδ T Cell Compartments. Cell. 2016;167:203-218.e17 pubmed publisher
  229. Takeda Y, Azuma M, Matsumoto M, Seya T. Tumoricidal efficacy coincides with CD11c up-regulation in antigen-specific CD8(+) T cells during vaccine immunotherapy. J Exp Clin Cancer Res. 2016;35:143 pubmed publisher
  230. Olofsson P, Steinberg B, Sobbi R, Cox M, Ahmed M, Oswald M, et al. Blood pressure regulation by CD4+ lymphocytes expressing choline acetyltransferase. Nat Biotechnol. 2016;34:1066-1071 pubmed publisher
  231. Hoegl S, Ehrentraut H, Brodsky K, Victorino F, Golden Mason L, Eltzschig H, et al. NK cells regulate CXCR2+ neutrophil recruitment during acute lung injury. J Leukoc Biol. 2017;101:471-480 pubmed publisher
  232. Lewis G, Wehrens E, Labarta Bajo L, Streeck H, Zuniga E. TGF-? receptor maintains CD4 T helper cell identity during chronic viral infections. J Clin Invest. 2016;126:3799-3813 pubmed publisher
  233. Ushiki T, Huntington N, Glaser S, Kiu H, Georgiou A, Zhang J, et al. Rapid Inflammation in Mice Lacking Both SOCS1 and SOCS3 in Hematopoietic Cells. PLoS ONE. 2016;11:e0162111 pubmed publisher
  234. Ladle B, Li K, Phillips M, Pucsek A, Haile A, Powell J, et al. De novo DNA methylation by DNA methyltransferase 3a controls early effector CD8+ T-cell fate decisions following activation. Proc Natl Acad Sci U S A. 2016;113:10631-6 pubmed publisher
  235. Ulges A, Witsch E, Pramanik G, Klein M, Birkner K, Bühler U, et al. Protein kinase CK2 governs the molecular decision between encephalitogenic TH17 cell and Treg cell development. Proc Natl Acad Sci U S A. 2016;113:10145-50 pubmed publisher
  236. Drennan M, Govindarajan S, Verheugen E, Coquet J, Staal J, McGuire C, et al. NKT sublineage specification and survival requires the ubiquitin-modifying enzyme TNFAIP3/A20. J Exp Med. 2016;213:1973-81 pubmed publisher
  237. Cordova Z, Grönholm A, Kytölä V, Taverniti V, Hämäläinen S, Aittomäki S, et al. Myeloid cell expressed proprotein convertase FURIN attenuates inflammation. Oncotarget. 2016;7:54392-54404 pubmed publisher
  238. Damgaard R, Walker J, Marco Casanova P, Morgan N, Titheradge H, Elliott P, et al. The Deubiquitinase OTULIN Is an Essential Negative Regulator of Inflammation and Autoimmunity. Cell. 2016;166:1215-1230.e20 pubmed publisher
  239. Carow B, Gao Y, Coquet J, Reilly M, Rottenberg M. lck-Driven Cre Expression Alters T Cell Development in the Thymus and the Frequencies and Functions of Peripheral T Cell Subsets. J Immunol. 2016;197:2261-8 pubmed publisher
  240. Zhao Y, Chu X, Chen J, Wang Y, Gao S, Jiang Y, et al. Dectin-1-activated dendritic cells trigger potent antitumour immunity through the induction of Th9 cells. Nat Commun. 2016;7:12368 pubmed publisher
  241. Leong Y, Chen Y, Ong H, Wu D, Man K, Deléage C, et al. CXCR5(+) follicular cytotoxic T cells control viral infection in B cell follicles. Nat Immunol. 2016;17:1187-96 pubmed publisher
  242. Cheng H, Gaddis D, Wu R, McSkimming C, Haynes L, Taylor A, et al. Loss of ABCG1 influences regulatory T cell differentiation and atherosclerosis. J Clin Invest. 2016;126:3236-46 pubmed publisher
  243. Hwang S, Cobb D, Bhadra R, Youngblood B, Khan I. Blimp-1-mediated CD4 T cell exhaustion causes CD8 T cell dysfunction during chronic toxoplasmosis. J Exp Med. 2016;213:1799-818 pubmed publisher
  244. Barin J, Talor M, Schaub J, Diny N, Hou X, Hoyer M, et al. Collaborative Interferon-? and Interleukin-17 Signaling Protects the Oral Mucosa from Staphylococcus aureus. Am J Pathol. 2016;186:2337-52 pubmed publisher
  245. Kang J, Park S, Jeong S, Han M, Lee C, Lee K, et al. Epigenetic regulation of Kcna3-encoding Kv1.3 potassium channel by cereblon contributes to regulation of CD4+ T-cell activation. Proc Natl Acad Sci U S A. 2016;113:8771-6 pubmed publisher
  246. Parsa R, Lund H, Georgoudaki A, Zhang X, Ortlieb Guerreiro Cacais A, Grommisch D, et al. BAFF-secreting neutrophils drive plasma cell responses during emergency granulopoiesis. J Exp Med. 2016;213:1537-53 pubmed publisher
  247. Baptista M, Keszei M, Oliveira M, Sunahara K, Andersson J, Dahlberg C, et al. Deletion of Wiskott-Aldrich syndrome protein triggers Rac2 activity and increased cross-presentation by dendritic cells. Nat Commun. 2016;7:12175 pubmed publisher
  248. Riedel A, Shorthouse D, Haas L, Hall B, Shields J. Tumor-induced stromal reprogramming drives lymph node transformation. Nat Immunol. 2016;17:1118-27 pubmed publisher
  249. Stadinski B, Shekhar K, Gomez Tourino I, Jung J, Sasaki K, Sewell A, et al. Hydrophobic CDR3 residues promote the development of self-reactive T cells. Nat Immunol. 2016;17:946-55 pubmed publisher
  250. Saha A, O Connor R, Thangavelu G, Lovitch S, Dandamudi D, Wilson C, et al. Programmed death ligand-1 expression on donor T cells drives graft-versus-host disease lethality. J Clin Invest. 2016;126:2642-60 pubmed publisher
  251. Goetz B, An W, Mohapatra B, Zutshi N, Iseka F, Storck M, et al. A novel CBL-Bflox/flox mouse model allows tissue-selective fully conditional CBL/CBL-B double-knockout: CD4-Cre mediated CBL/CBL-B deletion occurs in both T-cells and hematopoietic stem cells. Oncotarget. 2016;7:51107-51123 pubmed publisher
  252. Contreras F, Prado C, Gonzalez H, Franz D, Osorio Barrios F, Osorio F, et al. Dopamine Receptor D3 Signaling on CD4+ T Cells Favors Th1- and Th17-Mediated Immunity. J Immunol. 2016;196:4143-9 pubmed publisher
  253. Xu A, Bhanumathy K, Wu J, Ye Z, Freywald A, Leary S, et al. IL-15 signaling promotes adoptive effector T-cell survival and memory formation in irradiation-induced lymphopenia. Cell Biosci. 2016;6:30 pubmed publisher
  254. Reynaldi A, Smith N, Schlub T, Venturi V, Rudd B, Davenport M. Modeling the dynamics of neonatal CD8+ T-cell responses. Immunol Cell Biol. 2016;94:838-848 pubmed publisher
  255. Swamy M, Pathak S, Grzes K, Damerow S, Sinclair L, van Aalten D, et al. Glucose and glutamine fuel protein O-GlcNAcylation to control T cell self-renewal and malignancy. Nat Immunol. 2016;17:712-20 pubmed publisher
  256. O Leary C, Riling C, Spruce L, Ding H, Kumar S, Deng G, et al. Ndfip-mediated degradation of Jak1 tunes cytokine signalling to limit expansion of CD4+ effector T cells. Nat Commun. 2016;7:11226 pubmed publisher
  257. Jackson S, Jacobs H, Arkatkar T, Dam E, Scharping N, Kolhatkar N, et al. B cell IFN-γ receptor signaling promotes autoimmune germinal centers via cell-intrinsic induction of BCL-6. J Exp Med. 2016;213:733-50 pubmed publisher
  258. Holmkvist P, Pool L, Hägerbrand K, Agace W, Rivollier A. IL-18R?-deficient CD4(+) T cells induce intestinal inflammation in the CD45RB(hi) transfer model of colitis despite impaired innate responsiveness. Eur J Immunol. 2016;46:1371-82 pubmed publisher
  259. Apostolidis S, Rodríguez Rodríguez N, Suárez Fueyo A, Dioufa N, Ozcan E, Crispín J, et al. Phosphatase PP2A is requisite for the function of regulatory T cells. Nat Immunol. 2016;17:556-64 pubmed publisher
  260. Tosiek M, Fiette L, El Daker S, Eberl G, Freitas A. IL-15-dependent balance between Foxp3 and RORγt expression impacts inflammatory bowel disease. Nat Commun. 2016;7:10888 pubmed publisher
  261. Leeth C, Racine J, Chapman H, Arpa B, Carrillo J, Carrascal J, et al. B-lymphocytes expressing an Ig specificity recognizing the pancreatic ß-cell autoantigen peripherin are potent contributors to type 1 diabetes development in NOD mice. Diabetes. 2016;65:1977-1987 pubmed publisher
  262. Flach A, Litke T, Strauss J, Haberl M, Gómez C, Reindl M, et al. Autoantibody-boosted T-cell reactivation in the target organ triggers manifestation of autoimmune CNS disease. Proc Natl Acad Sci U S A. 2016;113:3323-8 pubmed publisher
  263. Buscher K, Wang H, Zhang X, Striewski P, Wirth B, Saggu G, et al. Protection from septic peritonitis by rapid neutrophil recruitment through omental high endothelial venules. Nat Commun. 2016;7:10828 pubmed publisher
  264. Haribhai D, Ziegelbauer J, Jia S, Upchurch K, Yan K, Schmitt E, et al. Alternatively Activated Macrophages Boost Induced Regulatory T and Th17 Cell Responses during Immunotherapy for Colitis. J Immunol. 2016;196:3305-17 pubmed publisher
  265. Kabat A, Harrison O, Riffelmacher T, Moghaddam A, Pearson C, Laing A, et al. The autophagy gene Atg16l1 differentially regulates Treg and TH2 cells to control intestinal inflammation. elife. 2016;5:e12444 pubmed publisher
  266. Hu H, Wang H, Xiao Y, Jin J, Chang J, Zou Q, et al. Otud7b facilitates T cell activation and inflammatory responses by regulating Zap70 ubiquitination. J Exp Med. 2016;213:399-414 pubmed publisher
  267. Vila Leahey A, Rogers D, Marshall J. The impact of ranitidine on monocyte responses in the context of solid tumors. Oncotarget. 2016;7:10891-904 pubmed publisher
  268. Schläger C, Körner H, Krueger M, Vidoli S, Haberl M, Mielke D, et al. Effector T-cell trafficking between the leptomeninges and the cerebrospinal fluid. Nature. 2016;530:349-53 pubmed publisher
  269. Ludigs K, Jandus C, Utzschneider D, Staehli F, Bessoles S, Dang A, et al. NLRC5 shields T lymphocytes from NK-cell-mediated elimination under inflammatory conditions. Nat Commun. 2016;7:10554 pubmed publisher
  270. Roffê E, Marino A, Weaver J, Wan W, de Araújo F, Hoffman V, et al. Trypanosoma cruzi Causes Paralyzing Systemic Necrotizing Vasculitis Driven by Pathogen-Specific Type I Immunity in Mice. Infect Immun. 2016;84:1123-1136 pubmed publisher
  271. Vieyra Garcia P, Wei T, Naym D, Fredholm S, Fink Puches R, Cerroni L, et al. STAT3/5-Dependent IL9 Overexpression Contributes to Neoplastic Cell Survival in Mycosis Fungoides. Clin Cancer Res. 2016;22:3328-39 pubmed publisher
  272. Kim K, Kim N, Lee G. Transcription Factors Oct-1 and GATA-3 Cooperatively Regulate Th2 Cytokine Gene Expression via the RHS5 within the Th2 Locus Control Region. PLoS ONE. 2016;11:e0148576 pubmed publisher
  273. Lin C, Bradstreet T, Schwarzkopf E, Jarjour N, Chou C, Archambault A, et al. IL-1-induced Bhlhe40 identifies pathogenic T helper cells in a model of autoimmune neuroinflammation. J Exp Med. 2016;213:251-71 pubmed publisher
  274. Bulla R, Tripodo C, Rami D, Ling G, Agostinis C, Guarnotta C, et al. C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation. Nat Commun. 2016;7:10346 pubmed publisher
  275. Atkinson S, Hoffmann U, Hamann A, Bach E, Danneskiold Samsøe N, Kristiansen K, et al. Depletion of regulatory T cells leads to an exacerbation of delayed-type hypersensitivity arthritis in C57BL/6 mice that can be counteracted by IL-17 blockade. Dis Model Mech. 2016;9:427-40 pubmed publisher
  276. Maelfait J, Roose K, Vereecke L, Mc Guire C, Sze M, Schuijs M, et al. A20 Deficiency in Lung Epithelial Cells Protects against Influenza A Virus Infection. PLoS Pathog. 2016;12:e1005410 pubmed publisher
  277. Luo C, Liao W, Dadi S, Toure A, Li M. Graded Foxo1 activity in Treg cells differentiates tumour immunity from spontaneous autoimmunity. Nature. 2016;529:532-6 pubmed publisher
  278. Catarinella M, Monestiroli A, Escobar G, Fiocchi A, Tran N, Aiolfi R, et al. IFNα gene/cell therapy curbs colorectal cancer colonization of the liver by acting on the hepatic microenvironment. EMBO Mol Med. 2016;8:155-70 pubmed publisher
  279. Metz P, Lopez J, Kim S, Akimoto K, Ohno S, Chang J. Regulation of Asymmetric Division by Atypical Protein Kinase C Influences Early Specification of CD8(+) T Lymphocyte Fates. Sci Rep. 2016;6:19182 pubmed publisher
  280. McDonald P, Read K, Baker C, Anderson A, Powell M, Ballesteros Tato A, et al. IL-7 signalling represses Bcl-6 and the TFH gene program. Nat Commun. 2016;7:10285 pubmed publisher
  281. Guo Z, Kong Q, Liu C, Zhang S, Zou L, Yan F, et al. DCAF1 controls T-cell function via p53-dependent and -independent mechanisms. Nat Commun. 2016;7:10307 pubmed publisher
  282. Goldberg G, Cornish A, Murphy J, Pang E, Lim L, Campbell I, et al. G-CSF and Neutrophils Are Nonredundant Mediators of Murine Experimental Autoimmune Uveoretinitis. Am J Pathol. 2016;186:172-84 pubmed publisher
  283. Mikyšková R, Štěpánek I, Indrová M, Bieblová J, Šímová J, Truxová I, et al. Dendritic cells pulsed with tumor cells killed by high hydrostatic pressure induce strong immune responses and display therapeutic effects both in murine TC-1 and TRAMP-C2 tumors when combined with docetaxel chemotherapy. Int J Oncol. 2016;48:953-64 pubmed publisher
  284. Vivar O, Masi G, Carpier J, Magalhaes J, Galgano D, Pazour G, et al. IFT20 controls LAT recruitment to the immune synapse and T-cell activation in vivo. Proc Natl Acad Sci U S A. 2016;113:386-91 pubmed publisher
  285. Sagoo P, Garcia Z, Breart B, Lemaître F, Michonneau D, Albert M, et al. In vivo imaging of inflammasome activation reveals a subcapsular macrophage burst response that mobilizes innate and adaptive immunity. Nat Med. 2016;22:64-71 pubmed publisher
  286. Ren Y, Wang N, Hu W, Zhang X, Xu J, Wan Y. Successive site translocating inoculation potentiates DNA/recombinant vaccinia vaccination. Sci Rep. 2015;5:18099 pubmed publisher
  287. Kiermaier E, Moussion C, Veldkamp C, Gerardy Schahn R, de Vries I, Williams L, et al. Polysialylation controls dendritic cell trafficking by regulating chemokine recognition. Science. 2016;351:186-90 pubmed publisher
  288. Jabara H, Boyden S, Chou J, Ramesh N, Massaad M, Benson H, et al. A missense mutation in TFRC, encoding transferrin receptor 1, causes combined immunodeficiency. Nat Genet. 2016;48:74-8 pubmed publisher
  289. Andzinski L, Kasnitz N, Stahnke S, Wu C, Gereke M, von Köckritz Blickwede M, et al. Type I IFNs induce anti-tumor polarization of tumor associated neutrophils in mice and human. Int J Cancer. 2016;138:1982-93 pubmed publisher
  290. Moretto M, Khan I. IL-21 Is Important for Induction of KLRG1+ Effector CD8 T Cells during Acute Intracellular Infection. J Immunol. 2016;196:375-84 pubmed publisher
  291. Chen S, Chang B, Chang S, Tong T, Ham S, Sherry B, et al. BTK inhibition results in impaired CXCR4 chemokine receptor surface expression, signaling and function in chronic lymphocytic leukemia. Leukemia. 2016;30:833-43 pubmed publisher
  292. Okada K, Sato S, Sato A, Mandelboim O, Yamasoba T, Kiyono H. Identification and Analysis of Natural Killer Cells in Murine Nasal Passages. PLoS ONE. 2015;10:e0142920 pubmed publisher
  293. Oh Y, Park H, Shin J, Lee J, Park H, Kho D, et al. Ndrg1 is a T-cell clonal anergy factor negatively regulated by CD28 costimulation and interleukin-2. Nat Commun. 2015;6:8698 pubmed publisher
  294. Finkin S, Yuan D, Stein I, Taniguchi K, Weber A, Unger K, et al. Ectopic lymphoid structures function as microniches for tumor progenitor cells in hepatocellular carcinoma. Nat Immunol. 2015;16:1235-44 pubmed publisher
  295. Ruan S, Samuelson D, Assouline B, Morre M, Shellito J. Treatment with Interleukin-7 Restores Host Defense against Pneumocystis in CD4+ T-Lymphocyte-Depleted Mice. Infect Immun. 2016;84:108-19 pubmed publisher
  296. Adachi T, Kobayashi T, Sugihara E, Yamada T, Ikuta K, Pittaluga S, et al. Hair follicle-derived IL-7 and IL-15 mediate skin-resident memory T cell homeostasis and lymphoma. Nat Med. 2015;21:1272-9 pubmed publisher
  297. Black L, Srivastava R, Schoeb T, Moore R, Barnes S, KABAROWSKI J. Cholesterol-Independent Suppression of Lymphocyte Activation, Autoimmunity, and Glomerulonephritis by Apolipoprotein A-I in Normocholesterolemic Lupus-Prone Mice. J Immunol. 2015;195:4685-98 pubmed publisher
  298. Ladell K, Hazenberg M, Fitch M, Emson C, McEvoy Hein Asgarian B, Mold J, et al. Continuous Antigenic Stimulation of DO11.10 TCR Transgenic Mice in the Presence or Absence of IL-1?: Possible Implications for Mechanisms of T Cell Depletion in HIV Disease. J Immunol. 2015;195:4096-105 pubmed publisher
  299. McCormack R, de Armas L, Shiratsuchi M, Fiorentino D, Olsson M, Lichtenheld M, et al. Perforin-2 is essential for intracellular defense of parenchymal cells and phagocytes against pathogenic bacteria. elife. 2015;4: pubmed publisher
  300. Martin Blondel G, Pignolet B, Tietz S, Yshii L, Gebauer C, Périnat T, et al. Migration of encephalitogenic CD8 T cells into the central nervous system is dependent on the α4β1-integrin. Eur J Immunol. 2015;45:3302-12 pubmed publisher
  301. Andersson K, Brisslert M, Cavallini N, Svensson M, Welin A, Erlandsson M, et al. Survivin co-ordinates formation of follicular T-cells acting in synergy with Bcl-6. Oncotarget. 2015;6:20043-57 pubmed
  302. Guo L, Huang Y, Chen X, Hu Li J, Urban J, Paul W. Innate immunological function of TH2 cells in vivo. Nat Immunol. 2015;16:1051-9 pubmed publisher
  303. Pearce V, Bouabe H, MacQueen A, Carbonaro V, Okkenhaug K. PI3Kδ Regulates the Magnitude of CD8+ T Cell Responses after Challenge with Listeria monocytogenes. J Immunol. 2015;195:3206-17 pubmed publisher
  304. Choi Y, Gullicksrud J, Xing S, Zeng Z, Shan Q, Li F, et al. LEF-1 and TCF-1 orchestrate T(FH) differentiation by regulating differentiation circuits upstream of the transcriptional repressor Bcl6. Nat Immunol. 2015;16:980-90 pubmed publisher
  305. Ngiow S, Young A, Jacquelot N, Yamazaki T, Enot D, Zitvogel L, et al. A Threshold Level of Intratumor CD8+ T-cell PD1 Expression Dictates Therapeutic Response to Anti-PD1. Cancer Res. 2015;75:3800-11 pubmed publisher
  306. Kaminsky L, Sei J, Parekh N, Davies M, Reider I, Krouse T, et al. Redundant Function of Plasmacytoid and Conventional Dendritic Cells Is Required To Survive a Natural Virus Infection. J Virol. 2015;89:9974-85 pubmed publisher
  307. Lowe K, Navarro Núñez L, Bénézech C, Nayar S, Kingston B, Nieswandt B, et al. The expression of mouse CLEC-2 on leucocyte subsets varies according to their anatomical location and inflammatory state. Eur J Immunol. 2015;45:2484-93 pubmed publisher
  308. Li Y, Shen C, Zhu B, Shi F, Eisen H, Chen J. Persistent Antigen and Prolonged AKT-mTORC1 Activation Underlie Memory CD8 T Cell Impairment in the Absence of CD4 T Cells. J Immunol. 2015;195:1591-8 pubmed publisher
  309. Kamimura D, Katsunuma K, Arima Y, Atsumi T, Jiang J, Bando H, et al. KDEL receptor 1 regulates T-cell homeostasis via PP1 that is a key phosphatase for ISR. Nat Commun. 2015;6:7474 pubmed publisher
  310. Conde P, Rodriguez M, van der Touw W, Jimenez A, Burns M, Miller J, et al. DC-SIGN(+) Macrophages Control the Induction of Transplantation Tolerance. Immunity. 2015;42:1143-58 pubmed publisher
  311. Deberge M, Ely K, Wright P, Thorp E, Enelow R. Shedding of TNF receptor 2 by effector CD8⁺ T cells by ADAM17 is important for regulating TNF-α availability during influenza infection. J Leukoc Biol. 2015;98:423-34 pubmed publisher
  312. Chen H, Sun J, Huang Z, Hou H, Arcilla M, Rakhilin N, et al. Comprehensive models of human primary and metastatic colorectal tumors in immunodeficient and immunocompetent mice by chemokine targeting. Nat Biotechnol. 2015;33:656-60 pubmed publisher
  313. Liechtenstein T, Perez Janices N, Blanco Luquin I, Goyvaerts C, Schwarze J, Dufait I, et al. Anti-melanoma vaccines engineered to simultaneously modulate cytokine priming and silence PD-L1 characterized using ex vivo myeloid-derived suppressor cells as a readout of therapeutic efficacy. Oncoimmunology. 2014;3:e945378 pubmed
  314. Thiault N, Darrigues J, Adoue V, Gros M, Binet B, Pérals C, et al. Peripheral regulatory T lymphocytes recirculating to the thymus suppress the development of their precursors. Nat Immunol. 2015;16:628-34 pubmed publisher
  315. Vuillefroy de Silly R, Ducimetière L, Yacoub Maroun C, Dietrich P, Derouazi M, Walker P. Phenotypic switch of CD8(+) T cells reactivated under hypoxia toward IL-10 secreting, poorly proliferative effector cells. Eur J Immunol. 2015;45:2263-75 pubmed publisher
  316. Moguche A, Shafiani S, Clemons C, Larson R, Dinh C, Higdon L, et al. ICOS and Bcl6-dependent pathways maintain a CD4 T cell population with memory-like properties during tuberculosis. J Exp Med. 2015;212:715-28 pubmed publisher
  317. Becker P, Hervouet C, Mason G, KWON S, Klavinskis L. Skin vaccination with live virus vectored microneedle arrays induce long lived CD8(+) T cell memory. Vaccine. 2015;33:4691-8 pubmed publisher
  318. Dahlgren M, Gustafsson Hedberg T, Livingston M, Cucak H, Alsén S, Yrlid U, et al. T follicular helper, but not Th1, cell differentiation in the absence of conventional dendritic cells. J Immunol. 2015;194:5187-99 pubmed publisher
  319. Bouchery T, Kyle R, Camberis M, Shepherd A, Filbey K, Smith A, et al. ILC2s and T cells cooperate to ensure maintenance of M2 macrophages for lung immunity against hookworms. Nat Commun. 2015;6:6970 pubmed publisher
  320. Olguín J, Fernández J, Salinas N, Juárez I, Rodriguez Sosa M, Campuzano J, et al. Adoptive transfer of CD4(+)Foxp3(+) regulatory T cells to C57BL/6J mice during acute infection with Toxoplasma gondii down modulates the exacerbated Th1 immune response. Microbes Infect. 2015;17:586-95 pubmed publisher
  321. Boding L, Hansen A, Nielsen M, Meroni G, Braunstein T, Woetmann A, et al. Midline 1 controls polarization and migration of murine cytotoxic T cells. Immun Inflamm Dis. 2014;2:262-71 pubmed publisher
  322. Rouhani S, Eccles J, Riccardi P, Peske J, Tewalt E, Cohen J, et al. Roles of lymphatic endothelial cells expressing peripheral tissue antigens in CD4 T-cell tolerance induction. Nat Commun. 2015;6:6771 pubmed publisher
  323. Vassena L, Giuliani E, Koppensteiner H, Bolduan S, Schindler M, Doria M. HIV-1 Nef and Vpu Interfere with L-Selectin (CD62L) Cell Surface Expression To Inhibit Adhesion and Signaling in Infected CD4+ T Lymphocytes. J Virol. 2015;89:5687-700 pubmed publisher
  324. Charlton J, Tsoukatou D, Mamalaki C, Chatzidakis I. Programmed death 1 regulates memory phenotype CD4 T cell accumulation, inhibits expansion of the effector memory phenotype subset and modulates production of effector cytokines. PLoS ONE. 2015;10:e0119200 pubmed publisher
  325. Van Den Ham K, Shio M, Rainone A, Fournier S, Krawczyk C, Olivier M. Iron prevents the development of experimental cerebral malaria by attenuating CXCR3-mediated T cell chemotaxis. PLoS ONE. 2015;10:e0118451 pubmed publisher
  326. Rao E, Zhang Y, Zhu G, Hao J, Persson X, Egilmez N, et al. Deficiency of AMPK in CD8+ T cells suppresses their anti-tumor function by inducing protein phosphatase-mediated cell death. Oncotarget. 2015;6:7944-58 pubmed
  327. Talaber G, Tuckermann J, Okret S. ACTH controls thymocyte homeostasis independent of glucocorticoids. FASEB J. 2015;29:2526-34 pubmed publisher
  328. Wensveen F, Jelenčić V, Valentić S, Šestan M, Wensveen T, Theurich S, et al. NK cells link obesity-induced adipose stress to inflammation and insulin resistance. Nat Immunol. 2015;16:376-85 pubmed publisher
  329. Hsiao H, Hsu T, Liu W, Hsieh W, Chou T, Wu Y, et al. Deltex1 antagonizes HIF-1α and sustains the stability of regulatory T cells in vivo. Nat Commun. 2015;6:6353 pubmed publisher
  330. Franckaert D, Schlenner S, Heirman N, Gill J, Skogberg G, Ekwall O, et al. Premature thymic involution is independent of structural plasticity of the thymic stroma. Eur J Immunol. 2015;45:1535-47 pubmed publisher
  331. Huang Y, Clarke F, Karimi M, Roy N, Williamson E, Okumura M, et al. CRK proteins selectively regulate T cell migration into inflamed tissues. J Clin Invest. 2015;125:1019-32 pubmed publisher
  332. Srivastava R, Khan A, Spencer D, Vahed H, Lopes P, Thai N, et al. HLA-A02:01-restricted epitopes identified from the herpes simplex virus tegument protein VP11/12 preferentially recall polyfunctional effector memory CD8+ T cells from seropositive asymptomatic individuals and protect humanized HLA-A*02:01 transgenic. J Immunol. 2015;194:2232-48 pubmed publisher
  333. Khan A, Srivastava R, Spencer D, Garg S, Fremgen D, Vahed H, et al. Phenotypic and functional characterization of herpes simplex virus glycoprotein B epitope-specific effector and memory CD8+ T cells from symptomatic and asymptomatic individuals with ocular herpes. J Virol. 2015;89:3776-92 pubmed publisher
  334. Zhang Y, Wu B, Metelli A, Thaxton J, Hong F, Rachidi S, et al. GP96 is a GARP chaperone and controls regulatory T cell functions. J Clin Invest. 2015;125:859-69 pubmed publisher
  335. Shrestha S, Yang K, Guy C, Vogel P, Neale G, Chi H. Treg cells require the phosphatase PTEN to restrain TH1 and TFH cell responses. Nat Immunol. 2015;16:178-87 pubmed publisher
  336. Singh S, Nehete P, Yang G, He H, Nehete B, Hanley P, et al. Enhancement of Mucosal Immunogenicity of Viral Vectored Vaccines by the NKT Cell Agonist Alpha-Galactosylceramide as Adjuvant. Vaccines (Basel). 2014;2:686-706 pubmed publisher
  337. Sakaguchi S, Hombauer M, Hassan H, Tanaka H, Yasmin N, Naoe Y, et al. A novel Cd8-cis-regulatory element preferentially directs expression in CD44hiCD62L+ CD8+ T cells and in CD8αα+ dendritic cells. J Leukoc Biol. 2015;97:635-44 pubmed publisher
  338. Krishnamoorthy N, Burkett P, Dalli J, Abdulnour R, Colas R, Ramon S, et al. Cutting edge: maresin-1 engages regulatory T cells to limit type 2 innate lymphoid cell activation and promote resolution of lung inflammation. J Immunol. 2015;194:863-7 pubmed publisher
  339. Li Q, Zou J, Wang M, Ding X, Chepelev I, Zhou X, et al. Critical role of histone demethylase Jmjd3 in the regulation of CD4+ T-cell differentiation. Nat Commun. 2014;5:5780 pubmed publisher
  340. Yuan X, Dee M, Altman N, Malek T. IL-2Rβ-dependent signaling and CD103 functionally cooperate to maintain tolerance in the gut mucosa. J Immunol. 2015;194:1334-46 pubmed publisher
  341. Skripuletz T, Manzel A, Gropengießer K, Schäfer N, Gudi V, Singh V, et al. Pivotal role of choline metabolites in remyelination. Brain. 2015;138:398-413 pubmed publisher
  342. White C, Villarino N, Sloan S, Ganusov V, Schmidt N. Plasmodium suppresses expansion of T cell responses to heterologous infections. J Immunol. 2015;194:697-708 pubmed publisher
  343. Stoycheva D, Deiser K, Stärck L, Nishanth G, Schlüter D, Uckert W, et al. IFN-γ regulates CD8+ memory T cell differentiation and survival in response to weak, but not strong, TCR signals. J Immunol. 2015;194:553-9 pubmed publisher
  344. Raker V, Stein J, Montermann E, Maxeiner J, Taube C, Reske Kunz A, et al. Regulation of IgE production and airway reactivity by CD4⁻CD8⁻ regulatory T cells. Immunobiology. 2015;220:490-9 pubmed publisher
  345. Thueson L, Emmons T, Browning D, Kreitinger J, Shepherd D, Wetzel S. In vitro exposure to the herbicide atrazine inhibits T cell activation, proliferation, and cytokine production and significantly increases the frequency of Foxp3+ regulatory T cells. Toxicol Sci. 2015;143:418-29 pubmed publisher
  346. Martin P, Dubois C, Jacquier E, Dion S, Mancini Bourgine M, Godon O, et al. TG1050, an immunotherapeutic to treat chronic hepatitis B, induces robust T cells and exerts an antiviral effect in HBV-persistent mice. Gut. 2015;64:1961-71 pubmed publisher
  347. Peters A, Burkett P, Sobel R, Buckley C, Watson S, Bettelli E, et al. Podoplanin negatively regulates CD4+ effector T cell responses. J Clin Invest. 2015;125:129-40 pubmed publisher
  348. Baptista A, Roozendaal R, Reijmers R, Koning J, Unger W, Greuter M, et al. Lymph node stromal cells constrain immunity via MHC class II self-antigen presentation. elife. 2014;3: pubmed publisher
  349. Mehta P, Nuotio Antar A, Smith C. γδ T cells promote inflammation and insulin resistance during high fat diet-induced obesity in mice. J Leukoc Biol. 2015;97:121-34 pubmed publisher
  350. Kern J, Drutel R, Leanhart S, Bogacz M, Pacholczyk R. Reduction of T cell receptor diversity in NOD mice prevents development of type 1 diabetes but not Sjögren's syndrome. PLoS ONE. 2014;9:e112467 pubmed publisher
  351. McKinstry K, Strutt T, Bautista B, Zhang W, Kuang Y, Cooper A, et al. Effector CD4 T-cell transition to memory requires late cognate interactions that induce autocrine IL-2. Nat Commun. 2014;5:5377 pubmed publisher
  352. Xie L, Choudhury G, Winters A, Yang S, Jin K. Cerebral regulatory T cells restrain microglia/macrophage-mediated inflammatory responses via IL-10. Eur J Immunol. 2015;45:180-91 pubmed publisher
  353. Bertin S, Lozano Ruiz B, Bachiller V, García Martínez I, Herdman S, Zapater P, et al. Dual-specificity phosphatase 6 regulates CD4+ T-cell functions and restrains spontaneous colitis in IL-10-deficient mice. Mucosal Immunol. 2015;8:505-15 pubmed publisher
  354. Chatterjee S, Thyagarajan K, Kesarwani P, Song J, Soloshchenko M, Fu J, et al. Reducing CD73 expression by IL1?-Programmed Th17 cells improves immunotherapeutic control of tumors. Cancer Res. 2014;74:6048-59 pubmed publisher
  355. Burton B, Britton G, Fang H, Verhagen J, Smithers B, Sabatos Peyton C, et al. Sequential transcriptional changes dictate safe and effective antigen-specific immunotherapy. Nat Commun. 2014;5:4741 pubmed publisher
  356. Schwartz M, Kolhatkar N, Thouvenel C, Khim S, Rawlings D. CD4+ T cells and CD40 participate in selection and homeostasis of peripheral B cells. J Immunol. 2014;193:3492-502 pubmed publisher
  357. Parker K, Sinha P, Horn L, Clements V, Yang H, Li J, et al. HMGB1 enhances immune suppression by facilitating the differentiation and suppressive activity of myeloid-derived suppressor cells. Cancer Res. 2014;74:5723-33 pubmed publisher
  358. Kreiser S, Eckhardt J, Kuhnt C, Stein M, Krzyzak L, Seitz C, et al. Murine CD83-positive T cells mediate suppressor functions in vitro and in vivo. Immunobiology. 2015;220:270-9 pubmed publisher
  359. Denton A, Roberts E, Linterman M, Fearon D. Fibroblastic reticular cells of the lymph node are required for retention of resting but not activated CD8+ T cells. Proc Natl Acad Sci U S A. 2014;111:12139-44 pubmed publisher
  360. Boding L, Hansen A, Meroni G, Johansen B, Braunstein T, Bonefeld C, et al. Midline 1 directs lytic granule exocytosis and cytotoxicity of mouse killer T cells. Eur J Immunol. 2014;44:3109-18 pubmed publisher
  361. Boyoglu Barnum S, Chirkova T, Todd S, Barnum T, Gaston K, Jorquera P, et al. Prophylaxis with a respiratory syncytial virus (RSV) anti-G protein monoclonal antibody shifts the adaptive immune response to RSV rA2-line19F infection from Th2 to Th1 in BALB/c mice. J Virol. 2014;88:10569-83 pubmed publisher
  362. Cowan J, McCarthy N, Parnell S, White A, Bacon A, Serge A, et al. Differential requirement for CCR4 and CCR7 during the development of innate and adaptive ??T cells in the adult thymus. J Immunol. 2014;193:1204-12 pubmed publisher
  363. Madireddi S, Eun S, Lee S, Nemčovičová I, Mehta A, Zajonc D, et al. Galectin-9 controls the therapeutic activity of 4-1BB-targeting antibodies. J Exp Med. 2014;211:1433-48 pubmed publisher
  364. Pastille E, Bardini K, Fleissner D, Adamczyk A, Frede A, Wadwa M, et al. Transient ablation of regulatory T cells improves antitumor immunity in colitis-associated colon cancer. Cancer Res. 2014;74:4258-69 pubmed publisher
  365. Smith N, Wissink E, Wang J, Pinello J, Davenport M, Grimson A, et al. Rapid proliferation and differentiation impairs the development of memory CD8+ T cells in early life. J Immunol. 2014;193:177-84 pubmed publisher
  366. Smolarchuk C, Zhu L, Chan W, Anderson C. T cells generated in the absence of a thoracic thymus fail to establish homeostasis. Eur J Immunol. 2014;44:2263-73 pubmed publisher
  367. Skrnjug I, Rueckert C, Libanova R, Lienenklaus S, Weiss S, Guzman C. The mucosal adjuvant cyclic di-AMP exerts immune stimulatory effects on dendritic cells and macrophages. PLoS ONE. 2014;9:e95728 pubmed publisher
  368. Kuwahara M, Suzuki J, Tofukuji S, Yamada T, Kanoh M, Matsumoto A, et al. The Menin-Bach2 axis is critical for regulating CD4 T-cell senescence and cytokine homeostasis. Nat Commun. 2014;5:3555 pubmed publisher
  369. Cochain C, Chaudhari S, Koch M, Wiendl H, Eckstein H, Zernecke A. Programmed cell death-1 deficiency exacerbates T cell activation and atherogenesis despite expansion of regulatory T cells in atherosclerosis-prone mice. PLoS ONE. 2014;9:e93280 pubmed publisher
  370. Fu H, Kishore M, Gittens B, Wang G, Coe D, Komarowska I, et al. Self-recognition of the endothelium enables regulatory T-cell trafficking and defines the kinetics of immune regulation. Nat Commun. 2014;5:3436 pubmed publisher
  371. Hirayama T, Asano Y, Iida H, Watanabe T, Nakamura T, Goitsuka R. Meis1 is required for the maintenance of postnatal thymic epithelial cells. PLoS ONE. 2014;9:e89885 pubmed publisher
  372. Lee J, Walsh M, Hoehn K, James D, Wherry E, Choi Y. Regulator of fatty acid metabolism, acetyl coenzyme a carboxylase 1, controls T cell immunity. J Immunol. 2014;192:3190-9 pubmed publisher
  373. Magri G, Miyajima M, Bascones S, Mortha A, Puga I, Cassis L, et al. Innate lymphoid cells integrate stromal and immunological signals to enhance antibody production by splenic marginal zone B cells. Nat Immunol. 2014;15:354-364 pubmed publisher
  374. Kim E, Gasper D, Lee S, Plisch E, Svaren J, Suresh M. Bach2 regulates homeostasis of Foxp3+ regulatory T cells and protects against fatal lung disease in mice. J Immunol. 2014;192:985-95 pubmed publisher
  375. Erlandsson M, Svensson M, Jonsson I, Bian L, Ambartsumian N, Andersson S, et al. Expression of metastasin S100A4 is essential for bone resorption and regulates osteoclast function. Biochim Biophys Acta. 2013;1833:2653-2663 pubmed publisher
  376. Yockey L, Demehri S, Turkoz M, Turkoz A, Ahern P, Jassim O, et al. The absence of a microbiota enhances TSLP expression in mice with defective skin barrier but does not affect the severity of their allergic inflammation. J Invest Dermatol. 2013;133:2714-2721 pubmed publisher
  377. Vink P, Smout W, Driessen Engels L, de Bruin A, Delsing D, Krajnc Franken M, et al. In vivo knockdown of TAK1 accelerates bone marrow proliferation/differentiation and induces systemic inflammation. PLoS ONE. 2013;8:e57348 pubmed publisher
  378. Koning J, Kooij G, de Vries H, Nolte M, Mebius R. Mesenchymal stem cells are mobilized from the bone marrow during inflammation. Front Immunol. 2013;4:49 pubmed publisher
  379. Zhang N, Bevan M. TGF-? signaling to T cells inhibits autoimmunity during lymphopenia-driven proliferation. Nat Immunol. 2012;13:667-73 pubmed publisher
  380. Chevrier S, Genton C, Malissen B, Malissen M, Acha Orbea H. Dominant Role of CD80-CD86 Over CD40 and ICOSL in the Massive Polyclonal B Cell Activation Mediated by LAT(Y136F) CD4(+) T Cells. Front Immunol. 2012;3:27 pubmed publisher
  381. Mathieu M, Cotta Grand N, Daudelin J, Boulet S, Lapointe R, Labrecque N. CD40-activated B cells can efficiently prime antigen-specific naïve CD8+ T cells to generate effector but not memory T cells. PLoS ONE. 2012;7:e30139 pubmed publisher
  382. Wojno E, Hosken N, Stumhofer J, O Hara A, Mauldin E, Fang Q, et al. A role for IL-27 in limiting T regulatory cell populations. J Immunol. 2011;187:266-73 pubmed publisher
  383. Zaragoza B, Evaristo C, Kissenpfennig A, Libri V, Malissen B, Rocha B, et al. Cell-to-cell interactions and signals involved in the reconstitution of peripheral CD8 T(CM) and T(EM) cell pools. PLoS ONE. 2011;6:e17423 pubmed publisher
  384. Guo Z, Li H, Han M, Xu T, Wu X, Zhuang Y. Modeling Sjögren's syndrome with Id3 conditional knockout mice. Immunol Lett. 2011;135:34-42 pubmed publisher
  385. Lin P, Sun L, Thibodeaux S, Ludwig S, Vadlamudi R, Hurez V, et al. B7-H1-dependent sex-related differences in tumor immunity and immunotherapy responses. J Immunol. 2010;185:2747-53 pubmed publisher
  386. Tait E, Jordan K, Dupont C, Harris T, Gregg B, Wilson E, et al. Virulence of Toxoplasma gondii is associated with distinct dendritic cell responses and reduced numbers of activated CD8+ T cells. J Immunol. 2010;185:1502-12 pubmed publisher
  387. Engstrom L, Bober L, Chen S, Fine J, Li Y, Stanton M, et al. Kinetic assessment and therapeutic modulation of metabolic and inflammatory profiles in mice on a high-fat and cholesterol diet. PPAR Res. 2010;2010:970164 pubmed publisher
  388. Sadri N, Lu J, Badura M, Schneider R. AUF1 is involved in splenic follicular B cell maintenance. BMC Immunol. 2010;11:1 pubmed publisher
  389. Schuhmann M, Stegner D, Berna Erro A, Bittner S, Braun A, Kleinschnitz C, et al. Stromal interaction molecules 1 and 2 are key regulators of autoreactive T cell activation in murine autoimmune central nervous system inflammation. J Immunol. 2010;184:1536-42 pubmed publisher
  390. Blache C, Adriouch S, Calbo S, Drouot L, Dulauroy S, Arnoult C, et al. Cutting edge: CD4-independent development of functional FoxP3+ regulatory T cells. J Immunol. 2009;183:4182-6 pubmed publisher
  391. Meyer Bahlburg A, Bandaranayake A, Andrews S, Rawlings D. Reduced c-myc expression levels limit follicular mature B cell cycling in response to TLR signals. J Immunol. 2009;182:4065-75 pubmed publisher
  392. Hamada H, Garcia Hernandez M, Reome J, Misra S, Strutt T, McKinstry K, et al. Tc17, a unique subset of CD8 T cells that can protect against lethal influenza challenge. J Immunol. 2009;182:3469-81 pubmed publisher
  393. Kastenmuller W, Gasteiger G, Stross L, Busch D, Drexler I. Cutting edge: mucosal application of a lyophilized viral vector vaccine confers systemic and protective immunity toward intracellular pathogens. J Immunol. 2009;182:2573-7 pubmed publisher
  394. Cooper M, Elliott J, Keyel P, Yang L, Carrero J, Yokoyama W. Cytokine-induced memory-like natural killer cells. Proc Natl Acad Sci U S A. 2009;106:1915-9 pubmed publisher
  395. Merck E, Voyle R, MacDonald H. Ly49D engagement on T lymphocytes induces TCR-independent activation and CD8 effector functions that control tumor growth. J Immunol. 2009;182:183-92 pubmed
  396. Iyer A, Pahar B, Boudreaux M, Wakamatsu N, Roy A, Chouljenko V, et al. Recombinant vesicular stomatitis virus-based west Nile vaccine elicits strong humoral and cellular immune responses and protects mice against lethal challenge with the virulent west Nile virus strain LSU-AR01. Vaccine. 2009;27:893-903 pubmed publisher
  397. Wells J, Cowled C, Farzaneh F, Noble A. Combined triggering of dendritic cell receptors results in synergistic activation and potent cytotoxic immunity. J Immunol. 2008;181:3422-31 pubmed
  398. Rana S, Byrne S, MacDonald L, Chan C, Halliday G. Ultraviolet B suppresses immunity by inhibiting effector and memory T cells. Am J Pathol. 2008;172:993-1004 pubmed publisher
  399. Sridhar S, Reyes Sandoval A, Draper S, Moore A, Gilbert S, Gao G, et al. Single-dose protection against Plasmodium berghei by a simian adenovirus vector using a human cytomegalovirus promoter containing intron A. J Virol. 2008;82:3822-33 pubmed publisher
  400. King S, Knorn A, Ohnmacht C, Voehringer D. Accumulation of effector CD4 T cells during type 2 immune responses is negatively regulated by Stat6. J Immunol. 2008;180:754-63 pubmed
  401. Allard E, Hardy M, Leignadier J, Marquis M, Rooney J, Lehoux D, et al. Overexpression of IL-21 promotes massive CD8+ memory T cell accumulation. Eur J Immunol. 2007;37:3069-77 pubmed
  402. Park S, Han Y, Aleyas A, George J, Yoon H, Lee J, et al. Low-dose antigen-experienced CD4+ T cells display reduced clonal expansion but facilitate an effective memory pool in response to secondary exposure. Immunology. 2008;123:426-37 pubmed
  403. Lepenies B, Cramer J, Burchard G, Wagner H, Kirschning C, Jacobs T. Induction of experimental cerebral malaria is independent of TLR2/4/9. Med Microbiol Immunol. 2008;197:39-44 pubmed
  404. Bliss S, Bliss S, Beiting D, Alcaraz A, Appleton J. IL-10 regulates movement of intestinally derived CD4+ T cells to the liver. J Immunol. 2007;178:7974-83 pubmed
  405. Stephens G, Andersson J, Shevach E. Distinct subsets of FoxP3+ regulatory T cells participate in the control of immune responses. J Immunol. 2007;178:6901-11 pubmed
  406. Agrewala J, Brown D, Lepak N, Duso D, Huston G, Swain S. Unique ability of activated CD4+ T cells but not rested effectors to migrate to non-lymphoid sites in the absence of inflammation. J Biol Chem. 2007;282:6106-15 pubmed
  407. Hamdy S, Elamanchili P, Alshamsan A, Molavi O, Satou T, Samuel J. Enhanced antigen-specific primary CD4+ and CD8+ responses by codelivery of ovalbumin and toll-like receptor ligand monophosphoryl lipid A in poly(D,L-lactic-co-glycolic acid) nanoparticles. J Biomed Mater Res A. 2007;81:652-62 pubmed
  408. Hofmann M, Brinkmann V, Zerwes H. FTY720 preferentially depletes naive T cells from peripheral and lymphoid organs. Int Immunopharmacol. 2006;6:1902-10 pubmed
  409. Hofmann M, Zerwes H. Identification of organ-specific T cell populations by analysis of multiparameter flow cytometry data using DNA-chip analysis software. Cytometry A. 2006;69:533-40 pubmed
  410. Dawes R, Hennig B, Irving W, Petrova S, Boxall S, Ward V, et al. Altered CD45 expression in C77G carriers influences immune function and outcome of hepatitis C infection. J Med Genet. 2006;43:678-84 pubmed
  411. Irwin S, Izzo A, Dow S, Skeiky Y, Reed S, Alderson M, et al. Tracking antigen-specific CD8 T lymphocytes in the lungs of mice vaccinated with the Mtb72F polyprotein. Infect Immun. 2005;73:5809-16 pubmed
  412. Getahun A, Hjelm F, Heyman B. IgE enhances antibody and T cell responses in vivo via CD23+ B cells. J Immunol. 2005;175:1473-82 pubmed
  413. Ise W, Nakamura K, Shimizu N, Goto H, Fujimoto K, Kaminogawa S, et al. Orally tolerized T cells can form conjugates with APCs but are defective in immunological synapse formation. J Immunol. 2005;175:829-38 pubmed
  414. Kelchtermans H, De Klerck B, Mitera T, Van Balen M, Bullens D, Billiau A, et al. Defective CD4+CD25+ regulatory T cell functioning in collagen-induced arthritis: an important factor in pathogenesis, counter-regulated by endogenous IFN-gamma. Arthritis Res Ther. 2005;7:R402-15 pubmed
  415. Yasumi T, Katamura K, Okafuji I, Yoshioka T, Meguro T, Nishikomori R, et al. Limited ability of antigen-specific Th1 responses to inhibit Th2 cell development in vivo. J Immunol. 2005;174:1325-31 pubmed
  416. Mischenko V, Kapina M, Eruslanov E, Kondratieva E, Lyadova I, Young D, et al. Mycobacterial dissemination and cellular responses after 1-lobe restricted tuberculosis infection of genetically susceptible and resistant mice. J Infect Dis. 2004;190:2137-45 pubmed
  417. Alcaide P, Fresno M. The Trypanosoma cruzi membrane mucin AgC10 inhibits T cell activation and IL-2 transcription through L-selectin. Int Immunol. 2004;16:1365-75 pubmed
  418. Tchilian E, Dawes R, Hyland L, Montoya M, Le Bon A, Borrow P, et al. Altered CD45 isoform expression affects lymphocyte function in CD45 Tg mice. Int Immunol. 2004;16:1323-32 pubmed
  419. Hequet O, Vocanson M, Saint Mezard P, Kaiserlian D, Nicolas J, Berard F. CD4+ T cells prevent skin autoimmunity during chronic autologous graft-versus-host-disease. Am J Transplant. 2004;4:872-8 pubmed
  420. Ishihara K, Sawa S, Ikushima H, Hirota S, Atsumi T, Kamimura D, et al. The point mutation of tyrosine 759 of the IL-6 family cytokine receptor gp130 synergizes with HTLV-1 pX in promoting rheumatoid arthritis-like arthritis. Int Immunol. 2004;16:455-65 pubmed
  421. Chen B, Cui X, Sempowski G, Domen J, Chao N. Hematopoietic stem cell dose correlates with the speed of immune reconstitution after stem cell transplantation. Blood. 2004;103:4344-52 pubmed
  422. Tardivel A, Tinel A, Lens S, Steiner Q, Sauberli E, Wilson A, et al. The anti-apoptotic factor Bcl-2 can functionally substitute for the B cell survival but not for the marginal zone B cell differentiation activity of BAFF. Eur J Immunol. 2004;34:509-18 pubmed
  423. Eruslanov E, Majorov K, Orlova M, Mischenko V, Kondratieva T, Apt A, et al. Lung cell responses to M. tuberculosis in genetically susceptible and resistant mice following intratracheal challenge. Clin Exp Immunol. 2004;135:19-28 pubmed
  424. Maris C, Miller J, Altman J, Jacob J. A transgenic mouse model genetically tags all activated CD8 T cells. J Immunol. 2003;171:2393-401 pubmed
  425. Noble A, Leggat J, Inderberg E. CD8+ immunoregulatory cells in the graft-versus-host reaction: CD8 T cells activate dendritic cells to secrete interleukin-12/interleukin-18 and induce T helper 1 autoantibody. Immunology. 2003;109:476-86 pubmed
  426. Otten L, Tacchini Cottier F, Lohoff M, Annunziato F, Cosmi L, Scarpellino L, et al. Deregulated MHC class II transactivator expression leads to a strong Th2 bias in CD4+ T lymphocytes. J Immunol. 2003;170:1150-7 pubmed
  427. Hoag K, Nashold F, Goverman J, Hayes C. Retinoic acid enhances the T helper 2 cell development that is essential for robust antibody responses through its action on antigen-presenting cells. J Nutr. 2002;132:3736-9 pubmed
  428. Wu T, Lee J, Lai Y, Hsu J, Tsai C, Lee Y, et al. Reduced expression of Bcl-2 in CD8+ T cells deficient in the IL-15 receptor alpha-chain. J Immunol. 2002;168:705-12 pubmed
  429. Nakayama T, Kasprowicz D, Yamashita M, Schubert L, Gillard G, Kimura M, et al. The generation of mature, single-positive thymocytes in vivo is dysregulated by CD69 blockade or overexpression. J Immunol. 2002;168:87-94 pubmed
  430. Schneider P, Takatsuka H, Wilson A, Mackay F, Tardivel A, Lens S, et al. Maturation of marginal zone and follicular B cells requires B cell activating factor of the tumor necrosis factor family and is independent of B cell maturation antigen. J Exp Med. 2001;194:1691-7 pubmed
  431. Campbell D, Kim C, Butcher E. Separable effector T cell populations specialized for B cell help or tissue inflammation. Nat Immunol. 2001;2:876-81 pubmed
  432. Zhang J, Kabra N, Cado D, Kang C, Winoto A. FADD-deficient T cells exhibit a disaccord in regulation of the cell cycle machinery. J Biol Chem. 2001;276:29815-8 pubmed
  433. Radoja S, Saio M, Frey A. CD8+ tumor-infiltrating lymphocytes are primed for Fas-mediated activation-induced cell death but are not apoptotic in situ. J Immunol. 2001;166:6074-83 pubmed
  434. Van Stipdonk M, Lemmens E, Schoenberger S. Naïve CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation. Nat Immunol. 2001;2:423-9 pubmed
  435. Attinger A, MacDonald H, Acha Orbea H. Lymphoid environment limits superantigen and antigen-induced T cell proliferation at high precursor frequency. Eur J Immunol. 2001;31:884-93 pubmed
  436. Magner W, Kazim A, Stewart C, Romano M, Catalano G, Grande C, et al. Activation of MHC class I, II, and CD40 gene expression by histone deacetylase inhibitors. J Immunol. 2000;165:7017-24 pubmed
  437. Jelley Gibbs D, Lepak N, Yen M, Swain S. Two distinct stages in the transition from naive CD4 T cells to effectors, early antigen-dependent and late cytokine-driven expansion and differentiation. J Immunol. 2000;165:5017-26 pubmed
  438. Ding Z, Babensee J, Simon S, Lu H, Perrard J, Bullard D, et al. Relative contribution of LFA-1 and Mac-1 to neutrophil adhesion and migration. J Immunol. 1999;163:5029-38 pubmed
  439. Zerrahn J, Volkmann A, Coles M, Held W, Lemonnier F, Raulet D. Class I MHC molecules on hematopoietic cells can support intrathymic positive selection of T cell receptor transgenic T cells. Proc Natl Acad Sci U S A. 1999;96:11470-5 pubmed
  440. Eberl G, Lees R, Smiley S, Taniguchi M, Grusby M, MacDonald H. Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells. J Immunol. 1999;162:6410-9 pubmed
  441. Katakai T, Mori K, Masuda T, Shimizu A. Differential localization of Th1 and Th2 cells in autoimmune gastritis. Int Immunol. 1998;10:1325-34 pubmed
  442. Liu L, Rich B, Inobe J, Chen W, Weiner H. Induction of Th2 cell differentiation in the primary immune response: dendritic cells isolated from adherent cell culture treated with IL-10 prime naive CD4+ T cells to secrete IL-4. Int Immunol. 1998;10:1017-26 pubmed
  443. Shen X, Konig R. Regulation of T cell immunity and tolerance in vivo by CD4. Int Immunol. 1998;10:247-57 pubmed
  444. Lepault F, Gagnerault M, Faveeuw C, Bazin H, Boitard C. Lack of L-selectin expression by cells transferring diabetes in NOD mice: insights into the mechanisms involved in diabetes prevention by Mel-14 antibody treatment. Eur J Immunol. 1995;25:1502-7 pubmed
  445. Ley K, Bullard D, Arbones M, Bosse R, Vestweber D, Tedder T, et al. Sequential contribution of L- and P-selectin to leukocyte rolling in vivo. J Exp Med. 1995;181:669-75 pubmed
  446. Lewinsohn D, Bargatze R, Butcher E. Leukocyte-endothelial cell recognition: evidence of a common molecular mechanism shared by neutrophils, lymphocytes, and other leukocytes. J Immunol. 1987;138:4313-21 pubmed
  447. Siegelman M, Cheng I, Weissman I, Wakeland E. The mouse lymph node homing receptor is identical with the lymphocyte cell surface marker Ly-22: role of the EGF domain in endothelial binding. Cell. 1990;61:611-22 pubmed
  448. Chaffin K, Perlmutter R. A pertussis toxin-sensitive process controls thymocyte emigration. Eur J Immunol. 1991;21:2565-73 pubmed